"NCT_id","matched_string","criteria_string","parent_concept_id","parent_concept_name","w.mod"
"NCT03937804","scoliosis","ve pulmonary disease, chronic obstructive airway disease,
             emphysema, chronic bronchitis, lung transplant, kyphoscoliosis, sarcoidosis,
             bronchopulmonary dysplasia, cystic fibr",72418,"Scoliosis deformity of spine",FALSE
"NCT00252252","scoliosis","ar disease (eg. old polio, bilateral diaphragm
             paralysis) or chest wall disease (eg. idiopathic scoliosis, thoracoplasty)

          -  Recruited from 1300 patients attending Royal Brompt",72418,"Scoliosis deformity of spine",FALSE
"NCT03329716","scoliosis","en wearing underarm (Boston) bracing, and who have reached
             skeletal maturity based on the Scoliosis Research Society (SRS) standardized criteria:
             Risser stage ≥4, >2 years po",72418,"Scoliosis deformity of spine",FALSE
"NCT03090971","scoliosis","-  a distinct osseous lesion, such as sphenoid wing dysplasia, pseudoarthrosis of the
             tibia, macrocephaly, or scoliosis

          -  a first-degree relative with NF1

          -  Presen",72418,"Scoliosis deformity of spine",FALSE
"NCT03404232","scoliosis","pine

          -  Relevant peripheral neuropathy

          -  Acute denervation subsequent to a radiculopathy

          -  Scoliosis with Cobb angle greater than 25°

          -  Spondylolisthesis",72418,"Scoliosis deformity of spine",FALSE
"NCT01467882","scoliosis"," or other study endpoints (e.g. chronic steroid use [except mild topical steroids],
             renal failure, diabetes, moderate to severe scoliosis, previously treated intracranial
             tum",72418,"Scoliosis deformity of spine",TRUE
"NCT03581084","scoliosis","tis, vocal cord dysfunction
             (that is the sole cause of respiratory symptoms and at the PI's discretion), severe
             scoliosis or chest wall deformities that affect lung function,",72418,"Scoliosis deformity of spine",TRUE
"NCT01926275","scoliosis","nced
             bronchiectases, active tuberculosis, post tuberculosis syndrome, pneumonia, severe
             kyphoscoliosis, tracheostoma, neuromuscular diseases, or any other disorder, which
   ",72418,"Scoliosis deformity of spine",TRUE
"NCT01784094","scoliosis",":

          -  previous severe back or lower extremity injury or surgery

          -  major structural spinal deformity (scoliosis, kyphosis, stenosis)

          -  ankylosing spondylitis or rheuma",72418,"Scoliosis deformity of spine",TRUE
"NCT02131090","scoliosis","men

          -  BMI < 50

        Exclusion Criteria:

          -  BMI >50

          -  Documented diagnosis of scoliosis and/or other significant lumbar spinal pathology

          -  Previous lu",72418,"Scoliosis deformity of spine",TRUE
"NCT02081430","muscle wasting","nce of central nervous system involvement such as exaggerated reflexes, changes
             in sensation in the hands, muscle wasting in the hands, impaired sensation of the
             face, altere",78236,"Muscle atrophy",FALSE
"NCT01571674","muscle wasting"," of central nervous system involvement, to include hyperreflexia, sensory
             disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during
             walking, nystag",78236,"Muscle atrophy",FALSE
"NCT03078543","muscular atrophy","ct has conditions that may interfere with the TKA survival or outcome (e.g.
             Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled
             diabetes mell",78236,"Muscle atrophy",FALSE
"NCT02668835","muscular atrophy","e - Multiple sclerosis, amyotrophic lateral sclerosis, motor
             neuritis, progressive bulbar palsy, progressive muscular atrophy, spinal muscular
             atrophy

          -  Significa",78236,"Muscle atrophy",FALSE
"NCT03981575","muscle wasting","udy:

          -  Known CTG repeat expansion size less than 100 repeats, unless there are clear cut
             signs of limb weakness and muscle wasting. This is in order to obtain a muscle tissue
",78236,"Muscle atrophy",FALSE
"NCT00394043","muscle atrophy","atency greater than
             0.2 ms

        Exclusion Criteria:

          -  severe CTS that has progressed to muscle atrophy

          -  pregnancy

          -  previous wrist surgery on the ",78236,"Muscle atrophy",TRUE
"NCT03424707","muscular atrophy","g confirmed
             degenerative spondylosis, severe arthritis or severe osteoporosis) (2) myositis,
             muscular atrophy, myotonia, myasthenia (3) peptic ulcer or duodenal ulcer (4)
   ",78236,"Muscle atrophy",TRUE
"NCT02741076","amyotrophy","on, severe or progressive lower extremity weakness or numbness, bowel or
             bladder dysfunction as a result of cauda equina compression, diabetic amyotrophy,
             meningitis, diskiti",78236,"Muscle atrophy",TRUE
"NCT03517319","muscle atrophy","fore screening

          -  history or plan for tendon lengthening surgery

          -  significant contracture ormuscle atrophy at the target joint or muscle

          -  concurrent treatment with",78236,"Muscle atrophy",TRUE
"NCT01427361","muscular atrophy"," Exclusion Criteria:

          1. Patient with infection or sepsis.

          2. Patient with any vascular insufficiency, muscular atrophy, or neuromuscular disease
             severe enough to com",78236,"Muscle atrophy",TRUE
"NCT00692172","systemic infection","al hematology values or history of an immunosuppressive
             disorder

          -  Serious local infection or systemic infection within 3 months prior to the first dose
             of alefac",132797,"Sepsis",FALSE
"NCT01865708","sepsis","n applicable) consent for enrollment.

        Exclusion Criteria:

          -  18 yo or older.

          -  Urosepsis at time of study enrollment

          -  Known bladder or genitourinary abnorm",132797,"Sepsis",FALSE
"NCT02370160","systemic infection","r infectious pulmonary parenchymal disease

          -  Presence of active CNS leukemia

          -  Presence of any uncontrolled systemic infection

          -  Documented uncontrolled seizure dis",132797,"Sepsis",FALSE
"NCT03737929","sepsis","    -  Contra-indication to transoesophageal echocardiogram (TEE)

          -  Carotid stenosis > 80%,

          -  Active infection or sepsis

          -  Pleural adhesions,

          -  Elevated",132797,"Sepsis",FALSE
"NCT02304978","sepsis","able angina or myocardial infarction in the acute phase (not older
             than two months)

          -  Severe sepsis (hospitalization)

          -  Cirrhosis stage Child C

          -  Chron",132797,"Sepsis",FALSE
"NCT01543022","systemic infection"," that will preclude insertion of the Symphony
             device.

         10. Moderate to severe aortic insufficiency (2+ or more).

         11. Ongoing systemic infection defined as two of the fo",132797,"Sepsis",TRUE
"NCT00758862","systemic infection","        Exclusion Criteria:

          -  Immunosuppressed state or other serious systemic disease

          -  Signs and/or symptoms of systemic infection, such as malaise and fever or local
       ",132797,"Sepsis",TRUE
"NCT03230916","sepsis"," been discontinued, or has received
             REL for any other reason.

          -  Has a current diagnosis of cystic fibrosis, meningitis, or severe sepsis.

          -  Is expected to survive ",132797,"Sepsis",TRUE
"NCT01687166","sepsis","nths) prior to enrollment

          -  Left atrial appendage closure device

          -  Any other significant uncontrolled or unstable medical condition (e.g. sepsis, acute
             metabolic i",132797,"Sepsis",TRUE
"NCT01078610","sepsis"," the drug or one of the other ingredients

          -  Active tuberculosis or other severe infections (e.g. sepsis and opportunistic
             infections)

          -  Moderate to severe cardiac ",132797,"Sepsis",TRUE
"NCT02432638","cleft palate","will include all infants regardless of syndromic diagnosis, other organ
             system abnormalities, cleft palate diagnosis or the presence of other concurrent
             craniofacial anomalie",135923,"Cleft palate",FALSE
"NCT03366740","cleft palate","     ICU support during the admission

          -  Birth defect like complex congenital heart diseases, cleft lip and cleft palate, Down
             syndrome and cerebral palsy and others that may i",135923,"Cleft palate",FALSE
"NCT02858388","cleft palate","sion Criteria:

          1. Outcomes of adenotonsillectomy

          2. Velo-palatal insufficiencies, cleft lip and cleft palate.

          3. Hearing loss of perceptual, and mixed type.

         ",135923,"Cleft palate",FALSE
"NCT00422981","cleft palate","harynx, except for surgical correction of the nasal septum or a ""broken
             nose"" at least 2 years previously, or surgical repair of cleft palate when <30 years
             of age.

        ",135923,"Cleft palate",FALSE
"NCT04023825","cleft palate","-  children between 5 months and 12 years old

          -  weight >5kg

          -  children undergoing cleft palate repair surgery with or without upper lip surgery

        Exclusion Criteria:

  ",135923,"Cleft palate",FALSE
"NCT02435407","cleft palate","ly significant)

        Exclusion Criteria:

          -  •A child who has an anatomical cause for feeding problems such as cleft palate or
             significant oromotor abnormality

            ",135923,"Cleft palate",TRUE
"NCT01021397","cleft palate","d
             topical antifungal agents are not excluded.

          -  Major congenital malformations, including congenital cleft palate, cytogenetic
             abnormalities, or serious chronic d",135923,"Cleft palate",TRUE
"NCT02975310","cleft palate"," not be able to complete the follow-up appointments/evaluations

          6. Have significant oral structural abnormalities, e.g. unrepaired cleft palate

          7. Septal deviation requiring corr",135923,"Cleft palate",TRUE
"NCT03236194","cleft palate"," a congenital anomaly or neonatal condition that significantly affects a
             newborn's feeding (e.g. cleft lip, cleft palate, metabolic disease)

          4. any major maternal morbidities a",135923,"Cleft palate",TRUE
"NCT01623310","cleft palate","onths before the screening visit

          -  Current, ongoing rhinitis medicamentosa (rebound rhinitis)

          -  Have significant oral structural abnormalities, eg, a cleft palate

          - ",135923,"Cleft palate",TRUE
"NCT00766818","hypothyroidism","tra® component

          -  Chronic hepatitis B and/or C virus infection

          -  Cushing's Syndrome

          -  Untreated hypothyroidism or hyperthyroidism

          -  Serum Creatinine > 1.",140673,"Hypothyroidism",FALSE
"NCT02607254","hypothyroidism","             symptomatic peripheral vascular disease including intermittent claudication,
             pernicious anemia, untreated hypothyroidism, venous insufficiency, or spinal stenosis.

         ",140673,"Hypothyroidism",FALSE
"NCT02895087","hypothyroid"," sleep disorder, Addison's disease, diabetes or thyroid/pituitary/adrenal/splenic
             disorder (note: corrected hypothyroid disorder may be allowed if recent Thyroid
             Stimulating ",140673,"Hypothyroidism",FALSE
"NCT02023554","hypothyroidism","h renal or hepatic dysfunction;

          -  patients with congestive heart failure;

          -  patients with hypothyroidism or hyperthyroidism;

          -  patients taking drugs likely to affec",140673,"Hypothyroidism",FALSE
"NCT03817125","hypothyroidism","trictive procedures such as
             banding, are permitted).

          7. Any diagnosis of autoimmune disease. Participants with Type I diabetes mellitus,
             hypothyroidism only requir",140673,"Hypothyroidism",FALSE
"NCT02532335","hypothyroidism","el surgery

        Inflammatory bowel disease

        Uncontrolled diabetes mellitus (fasting blood glucose >6.7 mmol/L), hypothyroidism or
        hyperthyroidism, or other significant endocrine di",140673,"Hypothyroidism",TRUE
"NCT00796783","hypothyroidism","           as those with severe obesity, major depression or a history of alcoholism.

          -  Uncontrolled, clinically significant hypothyroidism or hyperthyroidism.

          -  Have renal fai",140673,"Hypothyroidism",TRUE
"NCT01140997","hypothyroidism","rocess, history of
             significant pulmonary disease or any history of interstitial lung disease.

          -  History of hypothyroidism or current treatment for thyroid disease.

          ",140673,"Hypothyroidism",TRUE
"NCT03379012","hypothyroidism","er; 5. Normal PSA level

        Exclusion Criteria:

          1. Prostate and other cancers history

          2. Hypothyroidism

          3. History of serious cardiac arrhythmia, congestive heart",140673,"Hypothyroidism",TRUE
"NCT01167127","hypothyroidism","th hypoxia and/or hypercapnia, severe obstructive pulmonary disease, cor
             pulmonale, severe bronchial asthma, paralytic ileus.

         15. Patients with myxodema, hypothyroidism, Addison",140673,"Hypothyroidism",TRUE
"NCT03595553","diarrhea"," of age, at the time of signing the informed consent.

          2. Signs and symptoms of CDI including diarrhea such that in the Investigator's opinion
             CDI antimicrobial therapy is requi",196523,"Diarrhea",FALSE
"NCT00998296","diarrhoea","   1. Active infectious disease

          2. Recent surgery within the last 4 weeks prior visit 1.

          3. Chronic diarrhoea or gastrointestinal tract disease resulting in an inability to take
",196523,"Diarrhea",FALSE
"NCT03833700","diarrhea","      6. Inability to take oral medication, or malabsorption syndrome or any other uncontrolled
             gastrointestinal condition (example: nausea, diarrhea, or vomiting) that might impair
     ",196523,"Diarrhea",FALSE
"NCT00275704","diarrhea","levels and might have additive effects
             when used with antidiabetic drugs).

          -  Diagnosis of/problems with chronic diarrhea or history of bowel obstruction or
             esopha",196523,"Diarrhea",FALSE
"NCT00563823","diarrhea"," limited to, any of the following
             conditions:

               -  Ulcerative disease

               -  Uncontrolled nausea

               -  Vomiting

               -  Diarrhea which mi",196523,"Diarrhea",FALSE
"NCT03739931","diarrhea","ongestive heart failure, uncontrolled hypertension, unstable
             angina pectoris, cardiac arrhythmia, ILD, serious chronic gastrointestinal conditions
             associated with diarrhea, o",196523,"Diarrhea",TRUE
"NCT00295607","diarrhoea","ngoing corticosteroid therapy.

          -  Patient has significant, uncontrolled concomitant infections and/or severe diarrhoea,
             vomiting, active upper gastro-intestinal tract malabsorp",196523,"Diarrhea",TRUE
"NCT03111511","diarrhea","             Disease [MDRD] formula12), significant cardiac, vascular, pulmonary, gastrointestinal
             (such as significant diarrhea, gastric stasis, or constipation that in the
             ",196523,"Diarrhea",TRUE
"NCT00183248","diarrhea","     3 times the upper value of the normal range within 28 days prior to study entry

          -  Uncontrolled concomitant infections, severe diarrhea, vomiting, active upper
             gastrointes",196523,"Diarrhea",TRUE
"NCT00540592","diarrhoea"," a
             moderate or severe illness with or without fever. All vaccines can be administered to
             persons with a minor illness such as diarrhoea, mild upper respiratory infection with",196523,"Diarrhea",TRUE
"NCT03378999","chronic obstructive pulmonary disease","al conditions that might interfere with the study, such as epilepsy,
             asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease,
             inflammatory bowel ",255573,"Chronic obstructive lung disease",FALSE
"NCT03131752","chronic obstructive lung disease","h genders, who are in a an exacerbation of the
             disease according to Global Initiative for Chronic Obstructive Lung Disease
             (GOLD,2015) refered by the doctors, hospitalized or",255573,"Chronic obstructive lung disease",FALSE
"NCT00605891","chronic obstructive lung disease","ional Heart Lung and Blood Institute/World Health Organization (NHLBI/WHO) Global
             Initiative for Chronic Obstructive Lung Disease (GOLD)

          -  Patient meets the following requirem",255573,"Chronic obstructive lung disease",FALSE
"NCT00137007","chronic obstructive pulmonary disease","         -  Bronchiectasis, bronchial obstruction or history of post-obstructive pneumonia
                  (this does not exclude patients with chronic obstructive pulmonary disease);

             ",255573,"Chronic obstructive lung disease",FALSE
"NCT02671942","chronic obstructive pulmonary disease","   .(postbronchodilator ≤0.7,，and a postbronchodilator FEV1≤50% predicted);

          3. Has a history of chronic obstructive pulmonary disease (COPD) (according to Global
             Initiative for",255573,"Chronic obstructive lung disease",FALSE
"NCT03794856","chronic obstructive pulmonary disease"," cord dysfunction (identified by abnormalities in spirometric
             flow-volume curves), clinically significant chronic obstructive pulmonary disease, or
             emphysema.

          -  P",255573,"Chronic obstructive lung disease",TRUE
"NCT03919422","chronic obstructive pulmonary disease","nerve injury or phrenic nerve injury

          5. Multiple trauma

          6. Uncontrolled respiratory disease (severe chronic obstructive pulmonary disease,
             asthma, pulmonary infectio",255573,"Chronic obstructive lung disease",TRUE
"NCT00642694","chronic obstructive pulmonary disease","         information, or evidence at examination; this includes severe sleep apnea, seizure
             disorder, or chronic obstructive pulmonary disease (COPD).

          -  Patient report or evid",255573,"Chronic obstructive lung disease",TRUE
"NCT02807675","chronic obstructive pulmonary disease","medications to treat orthostatic hypotension (for example droxidopa, fludrocortisone),
             if they have severe dysautonomia

          -  have chronic obstructive pulmonary disease (COPD), as",255573,"Chronic obstructive lung disease",TRUE
"NCT02532647","chronic obstructive pulmonary disease","               Examples may include poorly controlled diabetes or hypertension, moderate to
                  severe chronic obstructive pulmonary disease, active hepatitis, heart failure or
         ",255573,"Chronic obstructive lung disease",TRUE
"NCT00671892","allergic rhinitis","   -  not an employee working for,or a student under the authority of the PI's

        Exclusion Criteria:

          -  allergic rhinitis past or present

          -  chronic illness resulting in a",257007,"Allergic rhinitis",FALSE
"NCT00682643","allergic rhinitis","cific IgE (such as RAST, PRIST) will not be allowed for the diagnosis
        of PAR.

        NOTE: Subjects who meet the above criteria and who also may have seasonal allergic rhinitis
        (SAR)",257007,"Allergic rhinitis",FALSE
"NCT00521040","allergic rhinitis","ion Criteria:

          -  male or female subjects ≥ 12 years

          -  2 year history of seasonal allergic rhinitis

          -  documented hypersensitivity to local seasonal allergens (grass p",257007,"Allergic rhinitis",FALSE
"NCT02727205","allergic rhinitis","        of Day 1 patch application.

         20. Reported a history of anaphylactic reaction to drugs. At the discretion of the
             Investigator, subjects with seasonal allergic rhinitis wit",257007,"Allergic rhinitis",FALSE
"NCT04103086","allergic rhinitis","   3. Prior history of heart failure.

          4. Prior history of atrial fibrillation.

          5. Prior history of allergic rhinitis, sinusitis, asthma and COPD.

          6. Deafness, mental i",257007,"Allergic rhinitis",FALSE
"NCT00239499","allergic rhinitis","a:

          -  Patients with significant diseases other than COPD.

          -  Patients with a history of asthma, allergic rhinitis or atopy or who have a total
             blood eosinophil count",257007,"Allergic rhinitis",TRUE
"NCT01529229","allergic rhinitis","sent of the patient or legal guardian;

          -  Clinical diagnosis of moderate - severe persistent allergic rhinitis according to the
             classification of ARIA (Allergic Rhinitis and It",257007,"Allergic rhinitis",TRUE
"NCT02953366","allergic rhinitis","     -  Signed Consent of the patient;

          -  Clinical diagnosis of moderate - severe persistent allergic rhinitis according to ARIA
             classification(Allergic Rhinitis and Its Impact",257007,"Allergic rhinitis",TRUE
"NCT01101022","allergic rhinitis","     ideation.

          3. The subject has a body mass index (BMI) of <18.5 or ≥40.

          4. Subject has a concurrent chronic or acute illness (such as severe allergic rhinitis or
             ",257007,"Allergic rhinitis",TRUE
"NCT02746042","allergic rhinitis","ate to severe co-morbid asthma, including allergic asthma

          5. Cystic fibrosis

          6. Perennial (e.g. patients with clinical symptoms of allergic rhinitis against house
             du",257007,"Allergic rhinitis",TRUE
"NCT01848769","exacerbation of asthma","ses of cardiovascular, renal or liver disease

          -  Known hypersensitivity to the active treatments

          -  Exacerbation of asthma symptoms within the previous 4 weeks

          -  Inab",257581,"Exacerbation of asthma",FALSE
"NCT00521040","exacerbation of asthma","l allergens (grass pollen)

          -  documented pollen-induced asthma

          -  without acute ongoing exacerbation of asthma or allergic rhinitis

          -  no continuous ongoing treatment ",257581,"Exacerbation of asthma",FALSE
"NCT01087515","exacerbation of asthma","thin the range 19-32 kg/m²

        Exclusion Criteria:

          -  History of lower respiratory tract infection and /or exacerbation of asthma within
             four weeks prior to the informed c",257581,"Exacerbation of asthma",FALSE
"NCT00493090","exacerbation of asthma","         -  Using in excess of twelve beta2 agonists during a twelve month period and/or
             experiencing an acute exacerbation of asthma requiring oral steroids in the last 12
             m",257581,"Exacerbation of asthma",FALSE
"NCT00748306","exacerbation of asthma","          Hypertension at screening is defined as persistent systolic BP >150 mmHg or diastolic
             BP > 90mmHg.

          4. Respiratory tract infection and/or exacerbation of asthma within",257581,"Exacerbation of asthma",FALSE
"NCT01290874","exacerbation of asthma","         5. Pregnancy or lactation or an unwillingness to maintain effective birth control.

          6. History of a significant exacerbation of asthma or respiratory tract infection in the
        ",257581,"Exacerbation of asthma",TRUE
"NCT00839124","exacerbation of asthma","     a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more than 2x",257581,"Exacerbation of asthma",TRUE
"NCT00448851","exacerbation of asthma"," a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

         15. Exacerbation of asthma more than 2x/wee",257581,"Exacerbation of asthma",TRUE
"NCT00839189","exacerbation of asthma","son of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more than 2x/week whic",257581,"Exacerbation of asthma",TRUE
"NCT00287378","exacerbation of asthma","           a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more t",257581,"Exacerbation of asthma",TRUE
"NCT03032757","hypertension","s such as: heart disease , metabolic disease such as phenylketonuria,
        rheumatoid arthritis, uncontrolled hypertension, poor lung function, or any health
        condition that might put the pa",316866,"Hypertensive disorder",FALSE
"NCT02047656","hypertension"," to 80 years of age
             inclusive.

          -  Patients with mild-to-moderate uncomplicated essential hypertension

        Exclusion Criteria:

        Part 1

          -  History of hype",316866,"Hypertensive disorder",FALSE
"NCT00375401","hypertension"," or = 30 kg/m2; > or = to 27 kg/m2 for those with
             obesity-related comorbidities including hypertension and dyslipidemia

        Exclusion Criteria:

          -  Pregnancy

          -  ",316866,"Hypertensive disorder",FALSE
"NCT03865615","high blood pressure","ory, and/or physical exam performed
             or reviewed by the study physician.

          -  Severely low blood (< 90/50) pressure or uncontrolled high blood pressure (>160/100).

          -  S",316866,"Hypertensive disorder",FALSE
"NCT00003928","hypertension","ine no greater than 1.5 mg/dL OR

          -  Creatinine clearance at least 60 mL/min

        Cardiovascular:

          -  No uncontrolled hypertension

          -  No myocardial infarction within",316866,"Hypertensive disorder",FALSE
"NCT03650933","hypertension","of grade Ⅲ of Ⅳ
             according to the New York Heart Association(NYHA) system, or occurrence of myocardial
             infarction, unstable arrhythmia, unstable angina or severe hypertension ",316866,"Hypertensive disorder",TRUE
"NCT00655798","high blood pressure","significantly affect the study outcome, including
             diabetes (type 1 or 2) cardiovascular disease and hypothyroidemy

          4. High blood pressure (age <55 y: DBP > 100 or SBP >160 mm H",316866,"Hypertensive disorder",TRUE
"NCT02801201","hypertension","gic contraindications:

          -  infection at the puncture site, systemic infection or severe sepsis

          -  intracranial hypertension

          -  uncompensated heart failure

          - ",316866,"Hypertensive disorder",TRUE
"NCT03882424","hypertension","pants on anticoagulant drugs, anemic or with known bleeding diatheses.

          -  Participants with a history of severe, uncontrolled hypertension, heart disease,
             cerebrovascular incid",316866,"Hypertensive disorder",TRUE
"NCT03197623","hypertension","       ability to participate for the duration of the study, such as clinically significant
             cardiovascular disease, uncontrollable hypertension, uncontrolled asthma, symptomatic
         ",316866,"Hypertensive disorder",TRUE
"NCT01779895","asthma","consent

        Exclusion Criteria:

          -  Anemia

          -  Allergy to any food or medication

          -  Asthma

          -  Family history of congenital immunodeficiency or chronic co",317009,"Asthma",FALSE
"NCT00584636","asthma","teria:

        Patient is between the ages of 2 and 8

          -  Has previously been diagnosed with asthma by any physician

          -  Has presented to the ED with an asthma exacerbation judged",317009,"Asthma",FALSE
"NCT03895411","bronchial asthma","tive in conventional treatment;

          2. Left ventricular ejection fraction (LVEF) ≤ 50%;

          3. Suffering from bronchial asthma;

          4. Resting sinus heart rate (HR) in newborns <9",317009,"Asthma",FALSE
"NCT03396445","asthma","             (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive
             drugs) except vitiligo or resolved childhood asthma/atopy.

          -  Known human immuno",317009,"Asthma",FALSE
"NCT02936817","asthma","ect who has undergone major surgery within 12 weeks of Visit 1 or has planned to
             undergo a major surgery before the end of the study.

         22. Subject with diagnosis of asthma.

    ",317009,"Asthma",FALSE
"NCT00075569","asthma","standard therapy

        Pulmonary

          -  No significant respiratory disease that is uncontrolled with standard therapy

          -  No history of asthma

        Immunologic

          -  HI",317009,"Asthma",TRUE
"NCT00895102","asthma","cancer (except basal cell carcinoma);

          -  clinically significant cardiovascular, respiratory (except mild asthma), renal,
             gastrointestinal, hematologic, neurologic, thyroid, or ",317009,"Asthma",TRUE
"NCT01425281","asthma"," and/or has known immunosuppressive or
             autoimmune disease (e.g. human immunodeficiency virus, systemic lupus erythematosus,
             rheumatoid arthritis, severe asthma requiring immu",317009,"Asthma",TRUE
"NCT00463567","asthma","ry disease, pulmonary tuberculosis, or clinically
             significant bronchiectasis

          -  Patients with a history of asthma (with further criteria)

          -  Patients with Type I or ",317009,"Asthma",TRUE
"NCT02614274","asthma","had a significant injury to the target joint within the past 12 months.

          4. Subject plans to have knee surgery in the next 2 months.

          5. Subject has had an asthma attack, hives, or",317009,"Asthma",TRUE
"NCT00548184","cardiomyopathy","traceptive method in women of
             child-bearing potential.

          -  Severe underlying chronic illness or disease.

          -  Cardiomyopathy or baseline LVEF less than 50%.

          ",321319,"Cardiomyopathy",FALSE
"NCT01031290","cardiomyopathy","er, schizophrenia, bipolar disorder, mania,
        or hypomania

        vii) History of myocardial infarction, angina, congestive heart failure, cardiomyopathy,
        stroke or transient ischemic ",321319,"Cardiomyopathy",FALSE
"NCT03057548","cardiomyopathy","tients with any corrected or uncorrected congenital heart disease

          -  Patients with a history of hypertrophic cardiomyopathy

          -  Patients with cardiomyopathy and a left ventricular",321319,"Cardiomyopathy",FALSE
"NCT01212094","cardiomyopathy"," risk of harm or
        prevent the patient from completing the study (such as, but not limited to cerebrovascular
        disease, ischemic cardiomyopathy, clotting disorder, brittle diabetes, neuro",321319,"Cardiomyopathy",FALSE
"NCT01092325","cardiomyopathy"," and 85
             years of age

          -  Have chronic Systolic HF due to primary/idiopathic dilated cardiomyopathy, coronary
             artery disease or hypertension, and stable for at least",321319,"Cardiomyopathy",FALSE
"NCT03065140","cardiomyopathy","    -  Presence of other significant concomitant heart diseases such as ischaemic, valvular,
             pericardial heart disease or cardiomyopathy, skeletal muscle disorders

          -  Healthy v",321319,"Cardiomyopathy",TRUE
"NCT00230230","cardiomyopathy","s
             participation in the study. In particular, diabetics, uncontrolled hypertensives, and
             subjects with clinically significant cardiomyopathy, prostatic hypertrophy, glaucoma,
",321319,"Cardiomyopathy",TRUE
"NCT02508623","cardiomyopathy","          -  significant coronary artery disease (angina NYHA III/IV), congestive heart failure
             (NYHA III/IV), relevant cardiomyopathy, history of myocardial infarct within the last
     ",321319,"Cardiomyopathy",TRUE
"NCT01416974","cardiomyopathy","hmia or unexplained syncope, not
             believed to be vasovagal in nature or due to dehydration

          -  History of severe non-ischemic cardiomyopathy with EF ≤20%

          -  Patients w",321319,"Cardiomyopathy",TRUE
"NCT00079443","cardiomyopathy","tributed to agents used in the study

          -  Impaired cardiac function: history of life threatening arrhythmias, MI within the
             preceding 6 months, severe CAD, cardiomyopathy, conges",321319,"Cardiomyopathy",TRUE
"NCT01718600","encephalopathy","tion.

          -  Patient has acute illness or unstable chronic illness (e.g. uncontrolled hypertension,
             hepatic encephalopathy, portal hypertension, ascites, and esophageal varices,
  ",372887,"Disorder of brain",FALSE
"NCT02564198","encephalopathy","lcers, fistulas or
             abscesses

          -  Active or recent history of hypertensive crisis or hypertensive encephalopathy

          -  Active non-healing wound or bone fracture

        ",372887,"Disorder of brain",FALSE
"NCT02990312","encephalopathy","     2. The following active opportunistic infections: Ongoing chronic infections such as
             progressive multifocal leukoencephalopathy (PML), disseminated cryptococcosis, chronic
          ",372887,"Disorder of brain",FALSE
"NCT01143246","encephalopathy","           an NSAID within the prior month (prescription or over the counter) is acceptable Note:
             Use of short-term (< 2 weeks) oral neomycin for acute encephalopathy is acceptable.

    ",372887,"Disorder of brain",FALSE
"NCT01546909","encephalopathy","vaccine components or to a vaccine
             containing the same substances

          -  Known personal history of encephalopathy, seizure disorder or progressive, evolving or
             unstabl",372887,"Disorder of brain",FALSE
"NCT03079167","encephalopathy","s than 7.00 OR base deficit greater than or equal to 12.0
                  mmol/L

          -  Moderate to severe encephalopathy, defined between one and six hours after birth by
             one or",372887,"Disorder of brain",TRUE
"NCT04045210","encephalopathy","s such as schizophrenia

          -  acute alcohol/substance intoxication or withdrawal

          -  severe metabolic encephalopathy

          -  patients on comfort care

          -  Patients not",372887,"Disorder of brain",TRUE
"NCT00147030","encephalopathy","r they meet the neurological
        abnormality entry criteria (B) by trained personnel:

        B. Moderate to severe encephalopathy, consisting of altered state of consciousness
        (lethargy,",372887,"Disorder of brain",TRUE
"NCT01059461","encephalopathy"," of moderate or severe
        HIE collected from his NICU's file. Criteria of neonatal asphyxia and encephalopathy
        according to the American College of Obstetricians and Gynecologist and Amer",372887,"Disorder of brain",TRUE
"NCT02640040","encephalopathy","    -  Patients are complicated with mental, neurological disorders (such as hypoxic-ischemic
             encephalopathy, epilepsy and dementia) or significant barriers to growth.

          -  Patie",372887,"Disorder of brain",TRUE
"NCT02612337","sensorineural hearing loss","t has experienced active vertigo during the lead-in period.

          -  Subject has documented asymmetric sensorineural hearing loss.

          -  Subject agrees to maintain their current treatment",374366,"Sensorineural hearing loss",FALSE
"NCT03664674","sensorineural hearing loss","t has experienced active vertigo during the lead-in period.

          -  Subject has documented asymmetric sensorineural hearing loss.

          -  Subject agrees to maintain their current treatment",374366,"Sensorineural hearing loss",FALSE
"NCT03897634","sensorineural hearing loss","2. Speak English as their primary language

          3. Normal or corrected to normal vision

          4. Sensorineural hearing loss with pure-tone thresholds 20-85 dB HL at octave frequencies
     ",374366,"Sensorineural hearing loss",FALSE
"NCT04041700","sensorineural hearing loss","onduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz)
             of ≤ 55 dB sensorineural hearing loss.

        OR Subject with single-sided sensorineural deafness who is ",374366,"Sensorineural hearing loss",FALSE
"NCT01481662","sensorineural hearing loss","         -  Age older than 18

          -  Two clinical features of the triad present: encephalopathy, sensorineural hearing loss
             assessed by audiogram, retinal artery occlusion assessed",374366,"Sensorineural hearing loss",FALSE
"NCT01072409","sensorineural hearing loss","e or older at the time of the study.

          -  Postlinguistic onset of bilateral severe-to-profound sensorineural hearing loss

          -  Bilateral severe-to-profound hearing loss that meets cu",374366,"Sensorineural hearing loss",TRUE
"NCT00589511","sensorineural hearing loss","riteria:

          -  1 year to 17 years, 11 months of age.

          -  Bilateral severe to profound sensorineural hearing loss for those 1 to 2 years of age.
             Severe hearing loss for t",374366,"Sensorineural hearing loss",TRUE
"NCT01092910","sensorineural hearing loss","tands the audiological test procedures and use of the Esteem System.

          -  Subject has mild to severe sensorineural hearing loss between 500 and 4000 Hz in the
             ear to be implanted",374366,"Sensorineural hearing loss",TRUE
"NCT00205881","sensorineural hearing loss","rience.

          2. Age 18 years or older.

          3. Postlingual onset of hearing loss.

          4. Sensorineural hearing loss of a severe or greater degree in both ears.

          5. Normal/",374366,"Sensorineural hearing loss",TRUE
"NCT01975571","sensorineural hearing loss","    Criterion for selection will be subject interest in preservation of residual hearing;
        severe sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing
        aid",374366,"Sensorineural hearing loss",TRUE
"NCT00107055","eye disorder"," and/or regarding which an ophthalmologist has recommended cataract
                  surgery);

               -  Other vision-impairing disorders (if a subject is aware of any eye disorder that
    ",375252,"Disorder of eye",FALSE
"NCT02565537","eye disorder","thin corneas.

          -  Patients with topographic evidence of keratoconus.

          -  Patients with ectatic eye disorders.

          -  Patients with autoimmune diseases.

          -  Patient",375252,"Disorder of eye",FALSE
"NCT03475147","eye disorder","Control

          -  Age matched 18-80 years of age.

          -  Healthy normal controls with no known eye disorders.

        Exclusion Criteria:

          -  Scotoma or any other ocular disorder",375252,"Disorder of eye",FALSE
"NCT00861484","eye disorder","evant abnormality

          -  History of psychiatric illness or suicidal attempts or behaviours

          -  History of any eye disorder or colour blind, excluding myopia and presbyopia

          ",375252,"Disorder of eye",FALSE
"NCT03751202","eye disorder","             with the absorption, distribution, metabolism or excretion of the drug.

         17. Use of oral or parenteral corticosteroids in the previous four 4 weeks

         18. Eye disorders es",375252,"Disorder of eye",FALSE
"NCT02193217","eye disorder"," significant endocrine, thyroid, hepatic, respiratory, gastrointestinal,
             renal, cardiovascular disease, eye disorder or history of psychiatric/psychotic
             disorder.

          ",375252,"Disorder of eye",TRUE
"NCT00170729","eye disorder","ye.

          -  Clinically significant trichiasis or other clinically relevant concurrent
             inflammatory/ infective eye disorders (e.g. conjunctivitis, episcleritis) except mild
         ",375252,"Disorder of eye",TRUE
"NCT04045496","eye disorder","     5. History or evidence of active infections (Grade ≥2).

          6. History or evidence of significant inflammatory or vascular eye disorder.

          7. History of an allogeneic bone marrow ",375252,"Disorder of eye",TRUE
"NCT01919996","eye disorder","itive rapid antigen detection test.

        Exclusion Criteria:

          -  History of clinically significant eye disorder that would interfere with protocol test
             procedures.

        ",375252,"Disorder of eye",TRUE
"NCT00892918","eye disorder","pterygium or clinical suspected conjunctival tumor.

          3. eye surgery in the last 6 months.

          4. eye disorders: severe dry eye syndrome, ocular surface diseases, glaucoma, recurrent
 ",375252,"Disorder of eye",TRUE
"NCT02334683","dystonia","on Criteria:

          -  18 years or older

          -  Confirmed diagnosis of focal upper extremity dystonia (FHD) or upper limb spasticity

          -  Stable onabotulinumtoxinA dose regimen wit",375800,"Dystonia",FALSE
"NCT02347579","dystonia","otor / Trophic: Reports of decreased range of motion and/or motor
                       dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail,
                       skin)

    ",375800,"Dystonia",FALSE
"NCT01592110","dystonia","nce or history of renal or hepatic insufficiency.

          -  Have known history, hypersensitivity or idiosyncratic reaction (including dystonias)
             to risperidone, paliperidone, and/or a",375800,"Dystonia",FALSE
"NCT00530790","dystonia","ndex,in which case to
             implement polysomnography), etc.

          -  Patients with complication of movement disorder (e.g. Parkinson's disease, dyskinesia,
             dystonia, etc.).

",375800,"Dystonia",FALSE
"NCT00580658","dystonia","
          -  Patients who are diagnosed with chronic, intractable (drug refractory)primary
             dystonia, including generalized and or segmental dystonia, hemidystonia, and cervical
         ",375800,"Dystonia",FALSE
"NCT03620279","dystonia","e spasticity or fixed contracture in the more affected limb that limits
             functional arm and hand use

          -  dystonia

          -  severe visual or auditory disorders that prevent l",375800,"Dystonia",TRUE
"NCT02671604","dystonia","         -  Patients with comorbid diseases that can cause increased muscular activity such as
             severe dystonia or status asthmaticus,

          -  Patients with renal or hepatic failure ",375800,"Dystonia",TRUE
"NCT01588574","dystonia","r female aged 18~75

          -  Have no clinically significant medical condition

          -  Cervical dystonia

        Exclusion Criteria:

          -  Pregnant or lactation

          -  Subjec",375800,"Dystonia",TRUE
"NCT03921450","dystonia","associated with impaired or aberrant
             movement, such as brain tumors, stroke, M. Parkinson, M. Huntington, dystonia, or
             severe head trauma with subsequent loss of consciousnes",375800,"Dystonia",TRUE
"NCT03704168","dystonia","coagulopathies, life threatening
             arrhythmias

          3. Upper respiratory airway obstruction, e.g: severe dystonia

          4. History of previous local surgery

          5. Any con",375800,"Dystonia",TRUE
"NCT02204839","background diabetic retinopathy"," 50 years.

          -  Suffering from, or diagnosed with a diabetes related complication (apart from mild
             background diabetic retinopathy).

          -  HbA1c >8.5%.

          -  Curr",376683,"Nonproliferative diabetic retinopathy",FALSE
"NCT02444767","background diabetic retinopathy","ion, ocular
             infection, corneal edema). Patients may have mild blepharitis, mild dry eye,
             cataracts, age-related macular degeneration or background diabetic retinopathy if, in",376683,"Nonproliferative diabetic retinopathy",FALSE
"NCT02208115","background diabetic retinopathy"," 50 years.

          -  Suffering from, or diagnosed with a diabetes related complication (apart from mild
             background diabetic retinopathy).

          -  HbA1c >8.5%.

          -  Curr",376683,"Nonproliferative diabetic retinopathy",FALSE
"NCT02639507","background diabetic retinopathy","sed and
             treated by an endocrinologist, internist or family medicine physician

          -  Background diabetic retinopathy

          -  DME with central subfield thickness (CST) > 325 µ",376683,"Nonproliferative diabetic retinopathy",FALSE
"NCT00664183","non proliferative diabetic retinopathy","s with a history of systemic diabetes (type I or II)

          -  Subject with a documented history of Non Proliferative Diabetic Retinopathy (NPDR)

          -  Subjects with no PVD at baseline exa",376683,"Nonproliferative diabetic retinopathy",FALSE
"NCT01698749","non proliferative diabetic retinopathy","following inclusion
             criteria shall be enrolled in the study:

               1. Patients of Non Proliferative Diabetic retinopathy (NPDR)with clinicaly
                  significant macul",376683,"Nonproliferative diabetic retinopathy",TRUE
"NCT03475407","non proliferative diabetic retinopathy","lling the following inclusion
        criteria shall be enrolled in the study:

          -  Patients of Non Proliferative Diabetic Retinopathy(NPDR) with clinically significant
             macular e",376683,"Nonproliferative diabetic retinopathy",TRUE
"NCT00352807","background diabetic retinopathy","                 severe dry eye). Patients with mild chronic blepharitis, age-related macular
                  degeneration, background diabetic retinopathy may be enrolled at the discretion
        ",376683,"Nonproliferative diabetic retinopathy",TRUE
"NCT00355446","background diabetic retinopathy","on, or severe
             dry eye). Patients with mild chronic blepharitis, age-related macular degeneration,
             background diabetic retinopathy may be enrolled at the discretion of the inv",376683,"Nonproliferative diabetic retinopathy",TRUE
"NCT01319487","non proliferative diabetic retinopathy"," in at least one eye (""study eye"")
             involving the center of the macula:

          5. Mild to severe non proliferative diabetic retinopathy (Early Treatment Diabetic
             Retinopat",376683,"Nonproliferative diabetic retinopathy",TRUE
"NCT00382083","hearing impairment","or read English or who are unable to complete the consent process or
             questionnaire for reasons such as hearing impairment or other physical or mental
             disabilities

          ",377889,"Hearing loss",FALSE
"NCT02901548","hearing loss","otential participants with irreversible toxicity that is not reasonably expected to
             be exacerbated by the investigational product may be included (e.g., hearing loss,
             periphe",377889,"Hearing loss",FALSE
"NCT03825627","hearing impairment"," implants inside the brain or any electrical medical device (e.g. pacemaker)
             in the body

          -  Visual or hearing impairment, to the extent that it interferes with task instruction",377889,"Hearing loss",FALSE
"NCT01332656","hearing impairment","t urine) or
             proteinuria >500 mg/24h

          9. Pre-existing peripheral neuropathy > grade 1 according to the NCI CTCAE V.4.03

         10. Pre-existing hearing impairment > grade 1

 ",377889,"Hearing loss",FALSE
"NCT02500589","impaired hearing","l be excluded:

          -  1.Active diagnosis of psychosis or dementia in their medical records

          -  2.Severely impaired hearing or speech

          -  3.Lack of telephone access

        ",377889,"Hearing loss",FALSE
"NCT01499628","hearing impairment","      -  Patients who are not fluent in English or are cognitively impaired

          -  Patients with serious hearing impairment

          -  Patients who are hospital inpatients, who are living in",377889,"Hearing loss",TRUE
"NCT03907748","hearing impairment","riteria:

          -  Dyads where either or both the caregiver or person with dementia have significant
             hearing impairments that are not resolved through the use of a hearing aid device ",377889,"Hearing loss",TRUE
"NCT02862379","hearing impairment","          -  Persons who gave consent to participate in the study

          -  Persons with severe visual or hearing impairment

        Exclusion Criteria:

          -  Patients with severe disease",377889,"Hearing loss",TRUE
"NCT03162328","hearing loss","n lesion).

          -  Individuals who self-report severe contact dermatitis or allergy to silicone, nickel
             or silver.

          -  Individuals who self-report moderate hearing loss.

",377889,"Hearing loss",TRUE
"NCT02590796","hearing impairment",":

          -  General Wards

               -  Unable to understand spoken task instructions

               -  Vision or hearing impairment severe enough to preclude testing or interview

         ",377889,"Hearing loss",TRUE
"NCT03777254","myopia","rization (CNV) for any reason other than
             AMD (such as fundus angioid streaks, ocular histoplasmosis, pathologic myopia,
             trauma);

          5. Afferent pupillary defect(APD);",379805,"Myopia",FALSE
"NCT01284309","myopia","s (LASIK) or photorefractive keratectomy (PRK) in any eye

          -  Ocular trauma within the past six months

          -  Severe myopia

          -  Diabetes, Type I or Type 2, with or without m",379805,"Myopia",FALSE
"NCT02590692","myopia","previous 3 months in any clinical trial of a drug by ocular or
             systemic administration (within previous 18 months for sustained release products)

         16. Axial myopia of greater tha",379805,"Myopia",FALSE
"NCT03025399","myopia","terfere the fundus examination、Non - diabetic
             retinopathy、uveitis、amotio retinae、optic nerve diseases and high myopia with fundus
             lesions et al.)

          2. Combined with ",379805,"Myopia",FALSE
"NCT03329638","myopia","blyopia or manifest strabismus including intermittent tropia

          -  Ocular disorders that potentially affect myopia or refractive power

          -  Previous or current use of contact lenses, ",379805,"Myopia",FALSE
"NCT03713268","myopia","      1. Healthy controls: Healthy eyes without known disease: refractive error including
             myopia and non-significant cataract is allowed. For selected testing pseudophakia is
            ",379805,"Myopia",TRUE
"NCT01335867","myopia","reatment with drugs with known retinotoxicity

          8. History of visual field defects or predisposing factors, including glaucoma, severe
             myopia, retinal disorders, cataracts, diabe",379805,"Myopia",TRUE
"NCT01705236","myopia","            optic neuropathy, active advanced glaucoma, injury of the optic nerve based on the
             ophthalmologist's clinical judgment

         11. history or presence of severe myopia

    ",379805,"Myopia",TRUE
"NCT02040298","myopia","thalmologic disease / Concomitant ophthalmologic disorders (e.g. diabetes,
             macular degeneration, glaucoma, severe myopia , etc).

          -  Myopia > -7 Diopters (Severe myopia)

      ",379805,"Myopia",TRUE
"NCT04063644","myopia","that have not undergone cataract surgery.

          -  Cases that do not accept surgery (weak corneas, high degree of myopia, sensitivity to
             light, severe dryness of the eyes or by their",379805,"Myopia",TRUE
"NCT02281292","proliferative diabetic retinopathy"," of the study.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Proliferative diabetic retinopathy in the study eye, with the exception of ",380096,"Proliferative retinopathy with diabetes mellitus",FALSE
"NCT00970723","proliferative diabetic retinopathy","DRD, patient under dialysis

          -  Other causes for macular edema (uveitis, epiretinal membrane)

          -  Proliferative diabetic retinopathy requiring panretinal photocoagulation at inclus",380096,"Proliferative retinopathy with diabetes mellitus",FALSE
"NCT02294474","proliferative diabetic retinopathy","ening visit.

          -  Hospitalization for diabetic ketoacidosis in the last 6 months before screening visit.

          -  Unstable proliferative diabetic retinopathy or any other rapidly progres",380096,"Proliferative retinopathy with diabetes mellitus",FALSE
"NCT03547206","proliferative diabetic retinopathy","dition that appears consistent with a
             reduction in visual acuity to <20/25, diabetic retinopathy beyond mild
             non-proliferative diabetic retinopathy not involving the macula, ",380096,"Proliferative retinopathy with diabetes mellitus",FALSE
"NCT03635814","proliferative diabetic retinopathy","esolved (e.g., foveal atrophy,
                  abnormal pigmentation, dense subfoveal hard exudate)

               3. Subject who has proliferative diabetic retinopathy.

               4. Subject ",380096,"Proliferative retinopathy with diabetes mellitus",FALSE
"NCT02461771","proliferative diabetic retinopathy","e study eye including amblyopia, anterior ischemic
             optic neuropathy, clinically significant diabetic macular edema, severe non
             proliferative diabetic retinopathy, or prolifer",380096,"Proliferative retinopathy with diabetes mellitus",TRUE
"NCT00717457","proliferative diabetic retinopathy","ithin the previous 6 months;

          -  evidence of clinically significant diabetic complications;

          -  known proliferative diabetic retinopathy;

          -  myocardial infarction (MI), ",380096,"Proliferative retinopathy with diabetes mellitus",TRUE
"NCT01310166","proliferative diabetic retinopathy"," History or presence of malignancy in the last 5 years

          -  Diabetic patients with moderate or severe non-proliferative diabetic retinopathy or
             proliferative diabetic retinopathy",380096,"Proliferative retinopathy with diabetes mellitus",TRUE
"NCT00060892","proliferative diabetic retinopathy","y of malignant neoplasm (clinical, laboratory or imaging), except
             for basal cell carcinoma of the skin.

          -  Subjects who have proliferative diabetic retinopathy or severe, non-p",380096,"Proliferative retinopathy with diabetes mellitus",TRUE
"NCT03272451","proliferative diabetic retinopathy","ctive bleeding or significant increased risk of bleeding, severe hepatic
             insufficiency, current peptic ulceration, proliferative diabetic retinopathy

          -  Uncontrolled hypertensi",380096,"Proliferative retinopathy with diabetes mellitus",TRUE
"NCT01487044","diabetic macular edema","ics, with an age of 18 years of older

          -  Vision of 20/40-20/400 in the Study Eye

          -  Diabetic Macular Edema as documented by SD-OCT and Fluorescein Angiogram.

        Exclusion C",380097,"Diabetic macular edema",FALSE
"NCT02193945","diabetic macular edema","d to:

               -  Neovascular age-related macular degeneration;

               -  Fibrovascular scar;

               -  Diabetic macular edema; and

               -  Proliferative diabetic r",380097,"Diabetic macular edema",FALSE
"NCT00050479","diabetic macular edema","rimary outcome (artificial tears are permitted).

          9. History of cancer and prognosis of survival of less than 3 years.

         10. Participants whose diabetic macular edema, in the opinion",380097,"Diabetic macular edema",FALSE
"NCT02862938","diabetic macular edema","is or other ocular inflammatory disease.

         11. Participant is receiving systemic steroids or other immunosuppressive medications.

         12. Participant has diabetic macular edema and/or di",380097,"Diabetic macular edema",FALSE
"NCT03505567","diabetic macular edema","sease study eye(s)
             at the study visit; and

          -  Subjects diagnosed with retinal pathology including but not limited to: Macular
             Degeneration, Diabetic Macular Edema,",380097,"Diabetic macular edema",FALSE
"NCT00656903","diabetic macular edema","ely compromise the visual acuity of the study eye including amblyopia,
             anterior ischemic optic neuropathy, clinically significant diabetic macular edema,
             severe non prolifera",380097,"Diabetic macular edema",TRUE
"NCT00473928","diabetic macular edema","        compromise the VA of the study eye including amblyopia, anterior ischemic optic
             neuropathy, clinically significant diabetic macular edema, severe non proliferative
             di",380097,"Diabetic macular edema",TRUE
"NCT00387582","diabetic macular edema"," Subjects will be eligible if the following criteria are met:

               -  Clinically significant diabetic macular edema (CSME) or clinically significant
                  diabetic macular edema",380097,"Diabetic macular edema",TRUE
"NCT00403156","diabetic macular edema","     could likely compromise the visual acuity of the study eye including amblyopia,
             anterior ischemic optic neuropathy, clinically significant diabetic macular edema,
             severe",380097,"Diabetic macular edema",TRUE
"NCT00815360","diabetic macular edema","I or Type II diabetes

        Disease related considerations:

          -  Study eye with clinically significant diabetic macular edema characterized by macular
             edema, peripheral nonper",380097,"Diabetic macular edema",TRUE
"NCT03452475","epilepsy","          7. Known hypersensitivity or contraindication to arterolane-piperaquine, DHA-piperaquine,
             artemisinin, mefloquine (epilepsy, major psychiatric illness) or primaquine

          ",380378,"Epilepsy",FALSE
"NCT00672659","epilepsy","        -  Significant physical illness which would interfere with trial assessments

          -  Reduced hepatic function

          -  Epilepsy

          -  History of cardiac dysrhythmia

       ",380378,"Epilepsy",FALSE
"NCT00061399","epilepsy","     15 or 3 to 8

          -  No evidence of hypoxic injury

        Exclusion Criteria

          -  History of epilepsy, mental retardation, or documented evidence of developmental
             dy",380378,"Epilepsy",FALSE
"NCT01866397","epilepsy","ir or probenecid.

          -  An expected survival of less than three days.

          -  Known alcohol dependency, epilepsy, pregnancy or liver failure.

          -  Infection with a ganciclovir o",380378,"Epilepsy",FALSE
"NCT02276625","epilepsy","     study

          -  (hydroxy)chloroquine or mefloquine use

          -  History of any neurological disorder including epilepsy or febrile seizures

          -  Pregnancy or breastfeeding

    ",380378,"Epilepsy",FALSE
"NCT01489267","epilepsy"," impaired individuals

          2. Schizophrenics

          3. Patients with severe kidney and liver disease, epilepsy, heart disease, pulmonary
             disease, cardiac arrhythmia, diabetes in",380378,"Epilepsy",TRUE
"NCT01050231","epilepsy","ical clips or mechanical devices

          -  Metallic hardware on scalp region

          -  prior diagnosis of seizure and epilepsy

          -  severe migraine headache

          -  currently pr",380378,"Epilepsy",TRUE
"NCT01777048","epilepsy","992)

          4. Those without written parental consent

          5. Those with brain pathology such as serious head injury, epilepsy, and intellectual
             disability (IQ < 70)

          ",380378,"Epilepsy",TRUE
"NCT01319344","epilepsy"," Patients with known cerebrovacular disease

          -  Patients with peripheral occlusive artery disease

          -  Patients with history of epilepsy

          -  Patients with severe hepatic d",380378,"Epilepsy",TRUE
"NCT00981383","epilepsy","ination < 24)

          -  Other neurologic conditions (Parkinson's disease, Huntington's chorea, history of
             epilepsy, birth trauma, significant traumatic brain injury, clinical stroke,
",380378,"Epilepsy",TRUE
"NCT03005704","thrombocytopenia","     -  Not taking antiplatelet therapy prior to participation

        Exclusion Criteria:

          -  Known thrombocytopenia, other coagulation disorder such as von Willebrand's disease,
         ",432870,"Thrombocytopenic disorder",FALSE
"NCT00923013","thrombocytopenia","       -  Neutropenia (ANC less than 1000 cells/microl).

          -  Anemia (Hgb less than 10g/dL).

          -  Thrombocytopenia (Plt less than 100,000/microl).

          -  Absolute lymphocyte c",432870,"Thrombocytopenic disorder",FALSE
"NCT00829439","thrombocytopenia","-  Stomach or intestinal ulcers

          -  Kidney disease

          -  Hematological problems, including anemia, leucopenia, and thrombocytopenia

          -  Used investigational drugs/intervent",432870,"Thrombocytopenic disorder",FALSE
"NCT00740090","thrombocytopenia","o: systemic lupus
        erythematosus, rheumatoid arthritis, multiple sclerosis, Sjogren's syndrome, or autoimmune
        thrombocytopenia.

        Laboratory evidence of possible autoimmune disea",432870,"Thrombocytopenic disorder",FALSE
"NCT01998789","thrombocytopenia","olesterolemia (> 350 mg/dL) or hypertriglyceridemia (> 500 mg/dL) within
             30 days prior to baseline.

          -  Thrombocytopenia (platelets < 50,000/mm3)

          -  Absolute neutroph",432870,"Thrombocytopenic disorder",FALSE
"NCT03980548","thrombocytopenia","urs.

        -

        Exclusion Criteria:

          1. General exclusion criteria will be a known history of leucopenia, thrombocytopenia, or
             severe hepatic or renal dysfunction, as w",432870,"Thrombocytopenic disorder",TRUE
"NCT02074358","thrombocytopenia"," 2 weeks prior to dosing

          -  History of any severe drug allergy including allergy to Heparin or history of
             Heparin-induced thrombocytopenia, hypersensitivity to PCCs or Factor X",432870,"Thrombocytopenic disorder",TRUE
"NCT03786757","thrombocytopenia","Clinically significant gastrointestinal bleeding within 12 months before
                  randomization;

               4. Thrombocytopenia, unknown severe anemia at screening or pre-randomization;
",432870,"Thrombocytopenic disorder",TRUE
"NCT03887026","thrombocytopenia","BV), or hepatitis C (HCV)
             antibody screen

          -  Any clinically significant abnormal laboratory or ECG test. Presence of
             thrombocytopenia at screening is exclusionary
",432870,"Thrombocytopenic disorder",TRUE
"NCT02387723","thrombocytopenia","1 L/min, moderate to
             severe claudication or morbid obesity

          6. Clinical significant anaemia, leukopenia, leukocytosis or thrombocytopenia

          7. Clinically significant ab",432870,"Thrombocytopenic disorder",TRUE
"NCT03014908","obesity","riteria:

          -  aged between 8 and 18

          -  normal-weight according to the International Obesity Task Force (IOTF) BMI criteria

          -  fasted for at least 8 hours.

        Exclu",433736,"Obesity",FALSE
"NCT00800852","obesity","nclusion Criteria:

          -  children with Prader-willi syndrome

          -  children with simple obesity

        Exclusion Criteria:

          -  subjects with diabetes mellitus (fasting plas",433736,"Obesity",FALSE
"NCT01920672","obesity","mal pressure hydrocephalus, Parkinson's disease, advanced
             heart failure (New York Heart Stage 3-4), morbid obesity (BMI > 35), and indications
             of restless legs syndrome or pe",433736,"Obesity",FALSE
"NCT03136835","obesity","/ comfort care

          -  Normal exclusions for MRI (e.g. claustrophobia, cardiac pacemaker, etc.)

          -  Obesity

          -  Infections/ anemia

          -  Smoker

          -  Serious ",433736,"Obesity",FALSE
"NCT01814735","adiposity","t circumference ≥ 90cm if male and ≥ 80cm if female (India-specific cutpoints for
             abdominal adiposity)

          3. Daily rice consumption (≥200grams/day, > ~2cups/day) as determined by ",433736,"Obesity",FALSE
"NCT04050969","obesity"," lipids unachievable with diet and
                  maximum doses of lipid lowering medications).

               -  Obesity-induced cardiomyopathy.

               -  Clinically significant obstruct",433736,"Obesity",TRUE
"NCT00654381","obesity","patic function

          3. History of severe allergy/hypersensitivity

          4. Treatment with anti-diabetic, anti obesity drugs, etc 3 months before Visit 1

          5. Fasting blood glucose ",433736,"Obesity",TRUE
"NCT01872754","obesity","atient considered ""full stomach"": Diabetes with
                  autonomic dysfunction, severe gastroesophageal reflux, severe obesity and morbid
                  hiatal hernia and any other situati",433736,"Obesity",TRUE
"NCT02430558","obesity","ul symptoms (subjective IKDC < 65,
                  no improvement for 3 months)

               -  No significant obesity (BMI < 30)

               -  Accompanying ligamentous and meniscal lesions,",433736,"Obesity",TRUE
"NCT02116335","obesity"," than 16 kg/m2 (severely and very severely underweight) or that is
             greater than 40 kg/m2 (Class III obesity)

          -  Having evidence of cardiovascular, pulmonary, renal, hepatic, ce",433736,"Obesity",TRUE
"NCT02345018","hemophilia a","on

          9. Coagulant disorders or increased risk for thrombo-embolic complications: known
             coagulant disorders such as hemophilia A, hemophilia B, Von Willebrand disease,
           ",434007,"Hereditary factor VIII deficiency disease",FALSE
"NCT02718677","hemophilia a","clinically documented during a 6 months period] and
             without inhibitors) male subjects with hemophilia A receiving routine prophylaxis
             treatment.

          2. Age:

         ",434007,"Hereditary factor VIII deficiency disease",FALSE
"NCT01891461","hemophilia a","          -  Participation in any other pharmaceutical or clinical investigation

               -  Bleeding disorders (Hemophilia A, Hemophilia B, Von Willebrand disease, factor
                  VII",434007,"Hereditary factor VIII deficiency disease",FALSE
"NCT02585635","haemophilia a","sion Criteria:

          -  People will be eligible to participate in the family survey if they have haemophilia A
             or B and are aged between 14 and 17 years, or if they are the parent of",434007,"Hereditary factor VIII deficiency disease",FALSE
"NCT04055051","hemophilia a","ollowing inclusion criteria are eligible for
        enrollment into the study:

          1. Congenital hemophilia A or B of any severity, who have and have not undergone a liver
             transpl",434007,"Hereditary factor VIII deficiency disease",FALSE
"NCT00916032","hemophilia a","ening

          -  Participant has provided signed informed consent

          -  Participant has severe hemophilia A, defined by a baseline FVIII level < 1% of normal,
             as tested at scre",434007,"Hereditary factor VIII deficiency disease",TRUE
"NCT03741881","haemophilia a"," time of signing informed consent.

          -  Severe (FVIII [factor 8] activity less than 1%) congenital haemophilia A or severe
             (FIX [factor 9] activity less than 1%) congenital haemo",434007,"Hereditary factor VIII deficiency disease",TRUE
"NCT02615691","hemophilia a","855 or
             plasma transfusion at any time prior to screening

          3. Participant has severe hemophilia A (Factor VIII (FVIII) < 1%) as determined by the
             central laboratory,",434007,"Hereditary factor VIII deficiency disease",TRUE
"NCT00759655","hemophilia a","usion Criteria:

          -  Male patients less than 6 years of age with moderately severe to severe hemophilia A
             (FVIII less than or equal to 2%).

          -  Treatment history of les",434007,"Hereditary factor VIII deficiency disease",TRUE
"NCT02137850","haemophilia a","-  Male, age below 6 years of age at the time of signing informed consent

          -  Diagnosis of severe haemophilia A (FVIII activity level 1%) based on medical records
             or central lab",434007,"Hereditary factor VIII deficiency disease",TRUE
"NCT02216630","alcohol dependence"," study results

          -  Subjects on chronic immunosuppressive or chemotherapeutic therapy

          -  Known drug or alcohol dependence or any other factors which will interfere with the
       ",435243,"Alcohol dependence",FALSE
"NCT03659305","alcohol dependence","urgical procedures including appendectomy in the last 12 weeks prior to the
             signing of the informed consent.

          -  History of drug or alcohol dependence - regular intake of more t",435243,"Alcohol dependence",FALSE
"NCT02623205","alcohol dependence","ppliances, or presence of shrapnel.

          9. Bipolar Disorder

         10. Lifetime history of psychosis

         11. Current drug or alcohol dependence or abuse (excluding nicotine) - within 6",435243,"Alcohol dependence",FALSE
"NCT00592254","alcohol dependence","actation

          5. Subjects with a known recent history (within the past 6 months) of illicit drug or
             alcohol dependence

          6. Sensory difficulties such as deafness or blindne",435243,"Alcohol dependence",FALSE
"NCT02643264","alcohol dependence","        1. Age 18 - 65

          2. Current Diagnostic and Statistical Manual (DSM-IV-TR) diagnosis of alcohol dependence

          3. Alcohol use in the past month

          4. Right handed (self-",435243,"Alcohol dependence",FALSE
"NCT03595293","alcohol dependence","ment Center residential patients with alcohol use disorder, moderate to
             severe (equivalent to Alcohol Dependence in DSM-IV-TR), or prescription opioid use
             disorder (pOUD)

  ",435243,"Alcohol dependence",TRUE
"NCT01420211","alcohol dependence","diseases which could affect drug metabolism or elimination

          -  history of any serious psychological disorder

          -  drug or alcohol dependence

          -  positive drug or alcohol s",435243,"Alcohol dependence",TRUE
"NCT00535002","alcohol dependence","    dependence, this would seriously compromise the feasibility of recruitment.
             Individuals with alcohol dependence will be excluded. However because of the high
             comorbidity ",435243,"Alcohol dependence",TRUE
"NCT02836067","alcohol dependence",". Spirometry criteria FEV1/FVC < 0.7 (definition of COPD) and GOLD (severe-very severe)
             Stage 3 or 4 within past 12 months

          9. A history of alcohol dependence within the 6 month",435243,"Alcohol dependence",TRUE
"NCT02728063","chronic alcoholism","c, pulmonary,
             hepatic, renal, hematologic, neoplastic, or infectious);

          -  With acute or severe chronic disease (chronic alcoholism, drug addiction) found
             incompati",435243,"Alcohol dependence",TRUE
"NCT02410720","dehydration"," clearance <30 mL/minute)

          -  Severe congestive heart failure (New York Heart Association [NYHA] class III or IV)

          -  Dehydration

          -  Laxative use or dependency

        ",435796,"Dehydration",FALSE
"NCT01724801","dehydration"," of liver metastases,
        or < 5 x ULN in case of liver metastases.

        The symptoms of increased intracranial pressure are uncontrolled after dehydration and
        cortisone treatment.

  ",435796,"Dehydration",FALSE
"NCT00683982","dehydration","le for rotavirus test

        Exclusion Criteria:

          -  Severe malnourishment

          -  Severe dehydration

          -  History of diarrhea more than 3 days previous hospitalization

   ",435796,"Dehydration",FALSE
"NCT00120744","dehydration","ious and non-bloody vomiting within 4 hours of triage

          -  Diarrhea

          -  Mild to moderate dehydration

        Exclusion Criteria:

          -  Weight less than 8 kilograms

       ",435796,"Dehydration",FALSE
"NCT01992900","dehydration"," height <70% of the median National Center
             for Health Statistics(NCHS)/WHO reference).

          -  Severe vomiting or dehydration.

          -  Presence of jaundice.

          -  Know",435796,"Dehydration",FALSE
"NCT03452306","dehydration","orm.

          -  ECG or vital signs abnormalities (clinically significant).

          -  Positive testing for alcohol, drugs, pregnancy.

          -  Dehydration due to diarrhea, vomiting, or othe",435796,"Dehydration",TRUE
"NCT00267293","dehydration","ellitis, renal dysfunction, hepatic dysfunction, or
             thrombocytopenia.

          -  Presence of moderate or severe dehydration.

          -  Inclusion in the trial on 3 previous occasion",435796,"Dehydration",TRUE
"NCT01755559","dehydration"," (i.e. measles,
             acute lower respiratory tract infection, otitis media, tonsillitis, abscess, severe
             diarrhoea with dehydration, etc.)

          -  History of a full treatmen",435796,"Dehydration",TRUE
"NCT01715207","dehydration","cipients

          8. Elevation of serum creatinine during follow-up (> 30% than baseline)

          9. Diarrhea, resulting severe dehydration

         10. Development of gout or ureter stone

    ",435796,"Dehydration",TRUE
"NCT04041791","dehydration"," first-line antibiotics
             for severe pneumonia such as readmission or meningitis

          -  Shock due to dehydration or severe dehydration (based on WHO definitions (5))
             req",435796,"Dehydration",TRUE
"NCT03304392","psychosis","gh suicide risk

          -  suicide attempt or hospitalization in the last year

          -  primary problems with psychosis, alcohol or drug problems, mania

          -  currently receiving activ",436073,"Psychotic disorder",FALSE
"NCT02793856","psychosis","anticoagulation

          -  Blood-borne infectious disease, e.g. hepatitis B

          -  History of mandatory custody because of psychosis or other psychological disease
             inappropriate",436073,"Psychotic disorder",FALSE
"NCT03567356","psychosis","usion Criteria:

          -  LFTs > 5x ULN

          -  Psychiatric or medical instability (eg suicidality, psychosis. Sickle Cell disease
             with frequent crises, etc) that would preclude",436073,"Psychotic disorder",FALSE
"NCT03661125","psychosis","         clinical assessments.

          -  Refuses to be withdrawn from quetiapine (see section 4.7).

          -  Has a family history of psychosis in a first degree relative

          -  Has poo",436073,"Psychotic disorder",FALSE
"NCT02293057","psychosis","rovider (as determined through referral partner);

          3. observable cognitive or developmental delays or active psychosis that would interfere
             with completing consent, assessment o",436073,"Psychotic disorder",FALSE
"NCT03396367","psychotic disorder"," communicate in English

        Exclusion Criteria:

          -  Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection
             of the Structured Clinical Intervi",436073,"Psychotic disorder",TRUE
"NCT04094922","psychotic disorder","one able to run PTSD Coach app

        Exclusion Criteria:

          -  Positive screening for bipolar disorder, psychotic disorder, ongoing substance
             disorder, or severe suicidality ac",436073,"Psychotic disorder",TRUE
"NCT02641028","psychotic disorder",", assessment or
             treatment in any significant fashion

          3. Any lifetime history of bipolar I, II; schizophrenia or any other psychotic disorders;
             personality disorder",436073,"Psychotic disorder",TRUE
"NCT03509844","psychotic disorder","   PTSD in International Classification of Diseases (ICD-11)

        Exclusion Criteria:

          -  severe psychotic disorder

          -  dissociative identity disorder (DID)

          -  activ",436073,"Psychotic disorder",TRUE
"NCT01716325","psychosis","bile phone

          -  No internet access

          -  Known hospitalization for severe psychiatric disorders (schizophrenia, psychosis)

          -  Known history of eating disorders (anorexia, b",436073,"Psychotic disorder",TRUE
"NCT01948908","developmental delay","blood) that cannot be readily
             cleared

          -  Inability to speak English or Spanish

          -  Developmental delay, psychiatric illness, neurologic impairment, or altered mental
",436077,"Developmental delay",FALSE
"NCT01354028","developmental delay","le and/or unable to be moved from the infant warmer

          -  Severe congenital anomalies likely to be associated with developmental delay

          -  Apgar score of ≤ 3 at 5 minutes of age

   ",436077,"Developmental delay",FALSE
"NCT03675321","developmental delay","ition that may explain symptoms

          -  Taking a medication that may explain symptoms

          -  Significant developmental delays

          -  Patients treated with a new drug affecting the ",436077,"Developmental delay",FALSE
"NCT01267136","developmental delay"," consistency.

        Exclusion Criteria:

          -  Child cannot self-assess pain due to conditions such as developmental delays,
             chromosomal abnormalities, and other syndromes.

   ",436077,"Developmental delay",FALSE
"NCT02344784","developmental delay","eriment.

        Exclusion Criteria:

          1. Autism.

          2. Chronic neurological diseases.

          3. Developmental delay.

          4. Psychotic or major effective disorder (psychot",436077,"Developmental delay",FALSE
"NCT02515383","developmental delay","physician, that would preclude
             participation in the study.

          2. Diagnosis of active psychosis, developmental delay, or severe cognitive impairment as
             determined by p",436077,"Developmental delay",TRUE
"NCT00763243","developmental delay","and language competence to complete basic word and
             sentence repetition tasks,

          -  no significant developmental delay or neurological condition that, in the opinion of
          ",436077,"Developmental delay",TRUE
"NCT02223650","developmental delay","s, or central retina

          -  Gestational age ≥ 32 weeks

          -  Birth weight > 1500 grams

          -  No Down syndrome or cerebral palsy

          -  No severe developmental delay which",436077,"Developmental delay",TRUE
"NCT03786224","developmental delay"," for outpatient level of
             care, in the opinion of the investigator.

        Exclusion Criteria:

        - Any severe developmental delays (including, but not limited to, Autism Spectrum ",436077,"Developmental delay",TRUE
"NCT03134950","developmental delay","           Inflammatory Bowel Diseases such as Ulcerative Colitis and Chron's Disease)

          -  documented developmental delay, severe cognitive impairment, or a thought disorder

          -  ev",436077,"Developmental delay",TRUE
"NCT00940693","bipolar disorder","aceptive methods

          -  Suicide or homicide risk

          -  Organic brain syndrome

          -  Any diagnosis of lifetime bipolar disorder or psychotic disorder, and any actual
            ",436665,"Bipolar disorder",FALSE
"NCT03406702","bipolar disorder","r myoclonic seizures are eligible for the study.

          3. Inadequately treated psychotic or mood disorder (e.g., schizophrenia, major
             depression, bipolar disorder).

          4. Pre",436665,"Bipolar disorder",FALSE
"NCT03913975","bipolar disorder","thy female athlete

        Exclusion Criteria:

          -  Any psychiatric disorder, e.g., depression, bipolar disorder, schizophrenic disorder,
             etc. as determined by clinical evaluati",436665,"Bipolar disorder",FALSE
"NCT02358343","bipolar disorder","depressant drugs;

          3. Evidence of cognitive impairment on Mini-Cog;

          4. Present or past psychosis or bipolar disorder I or II on the MINI;

          5. Alcohol or substance abuse ",436665,"Bipolar disorder",FALSE
"NCT00223639","bipolar disorder","c interview using the Structured Clinical Interview for DSM-IV.

          -  Acute or chronic organic brain syndrome, schizophrenia, bipolar disorder, or any
             psychotic disorder.

       ",436665,"Bipolar disorder",FALSE
"NCT03884933","bipolar disorder","ed on Deslespaul's
        conceptualisation of SMI:

          1. meets criteria for (and presence of) bipolar disorder, severe major depression,
             schizophrenia, schizophreniform, and sch",436665,"Bipolar disorder",TRUE
"NCT03043261","bipolar disorder","dy
             participation (assessment, online interactive learning)

          -  History or presence of psychoses, bipolar disorder, and/or severe personality
             disorders as evaluated ",436665,"Bipolar disorder",TRUE
"NCT00926588","bipolar disorder"," do not speak English;

          -  have moderately severe cognitive impairment;

          -  have schizophrenia, bipolar disorder, or other psychosis;

          -  are actively suicidal;

        ",436665,"Bipolar disorder",TRUE
"NCT03706001","bipolar disorder","     -  Combine with any type of malignant tumor;

          -  Combine with other serious mental illnesses such as bipolar disorder, schizophrenia,
             schizophrenia-like illness, severe dem",436665,"Bipolar disorder",TRUE
"NCT02037022","bipolar disorder"," of age or older

        Exclusion Criteria:

          -  Current or lifetime diagnosis of severe psychiatric disorder, such as bipolar disorder

          -  Receiving in-home Applied Behavior Anal",436665,"Bipolar disorder",TRUE
"NCT04139876","bleeding","usion Criteria:

          -  The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding
             resistant to rubber band ligation or sclerotherapy

          -  The patient",437312,"Bleeding",FALSE
"NCT01994902","bleeding","rtical hormone) systemically or locally in the peristomal area.

          5. Currently suffering from peristomal skin problems i.e. bleeding or broken (weeping)
             skin.

          6. Are c",437312,"Bleeding",FALSE
"NCT00563758","bleeding","een performed
             within the past 5 years. In addition, there should not be history or evidence of
             weight loss, anemia or rectal bleeding since the evaluation was performed.

   ",437312,"Bleeding",FALSE
"NCT00396292","bleeding","ion to oral or IV iron (VIT-45)

          -  Documented history of discontinuing oral iron

          -  Significant bleeding

          -  History of anemia other that iron deficiency anemia

      ",437312,"Bleeding",FALSE
"NCT03707639","bleeding"," ≥3 months. With normal electrocardiogram results and no history of
        congestive heart failure.

        Without bleeding and thrombosis disease. With normal coagulation function: activated
    ",437312,"Bleeding",FALSE
"NCT00502086","bleeding"," related to severe
             liver failure (hepatic encephalopathy, hepatorenal syndrome, gastrointestinal
             bleeding, serum bilirubin level greater than 5 mg/dL, international normalize",437312,"Bleeding",TRUE
"NCT00597402","bleeding","infarction within 6 months

          -  History of stroke within 6 months

          -  Clinically significant peripheral vascular disease

          -  Evidence of bleeding diathesis

          -  C",437312,"Bleeding",TRUE
"NCT00003107","hemorrhage","ed hyper or hypothyroidism No Cushing's disease
        Gastrointestinal: No clinically significant gastrointestinal hemorrhages No uncontrolled
        peptic ulcer disease No history of inflammatory",437312,"Bleeding",TRUE
"NCT01100879","bleeding"," g/L.

          -  Known chronic renal failure, glomerular filtration rate <30 mL/min/m2.

          -  Recent (within last 4 weeks) significant bleeding/surgery, defined as drop in Hb of ≥2
        ",437312,"Bleeding",TRUE
"NCT01800240","bleeding","          -  History of significant blood loss due to any reason, including blood donation in the
             past 3 months.

          -  History of pre-existing bleeding disorder.

          -  Exi",437312,"Bleeding",TRUE
"NCT00962845","malaria","systemic lupus erythematosus

          -  No concurrent disease-modifying anti-rheumatic drugs

          -  No concurrent hydroxychloroquine for treatment or prophylaxis of malaria

          -  No ",438067,"Malaria",FALSE
"NCT02511353","malaria","iteria:

          -  Symptomatic, uncomplicated Plasmodium falciparum infection

          -  Positive malaria microscopy or malaria RDT (pLDH)

          -  Age: 18-50 years

          -  Provide wr",438067,"Malaria",FALSE
"NCT02859350","malaria","lunteers, parents or legal representatives and relevant assent for children
             participants as applicable.

          -  Free from malaria parasitemia by blood smear at enrollment and by PCR",438067,"Malaria",FALSE
"NCT01107145","malaria"," or mixed infection/ parasitemia (P. vivax and
             another species of Plasmodium, i.e. P. vivax, P. ovale, or P. malariae)

          -  History of allergy or hypersensitivity to intervention",438067,"Malaria",FALSE
"NCT02004574","malaria","tus on
             the treatment area

         19. Planned initiation of, or changes to, concomitant medication that could affect
             psoriasis vulgaris (e.g. beta blockers, anti-malarials,",438067,"Malaria",FALSE
"NCT02535767","malaria","R2000 G6PD qualitative test

        Exclusion Criteria:

          -  Moderate to severe anemia (Hb < 10 g/dL)

          -  Malaria infection by blood smear

          -  Individuals with known posi",438067,"Malaria",TRUE
"NCT01758159","malaria"," last 4 months

        Exclusion Criteria:

          -  With severe anemia (Hemoglobin < 50g/L)

          -  Malaria test positive with Immuno-chromatographic test (ICT)

          -  Mothers/ Care",438067,"Malaria",TRUE
"NCT00386750","malaria","f fever (temperature ≥ 37.5°C)

        Exclusion Criteria

          -  Signs/symptoms of severe/complicated malaria

          -  Ingestion of various antimalarial drugs, or antibiotics in the previ",438067,"Malaria",TRUE
"NCT01052584","malaria","blood draws and return visits.

        Exclusion Criteria:

          -  General danger signs or symptoms of severe malaria

          -  Signs or symptoms of severe malnutrition, defined as weight-f",438067,"Malaria",TRUE
"NCT01156896","malaria",";

          -  body weight <65 kg.

        Exclusion Criteria:

          -  presence of severe or complicated malaria as defined by WHO criteria;

          -  clinical evidence of ill health or a ",438067,"Malaria",TRUE
"NCT01973114","vertigo","and 70dB

          -  Speech discrimination score in silence: No better than 85%

          -  At least three vertigo attacks (lasting ≥ 20 minutes) during the last three months
             prior to",439383,"Vertigo",FALSE
"NCT03089021","vertigo","   -  Fibromyalgia pain syndrome.

               -  Previous neck surgery.

               -  Neck pain associate with vertigo caused by vertebrobasilar insufficiency or
                  chronic hea",439383,"Vertigo",FALSE
"NCT00765336","vertigo","dietary supplements containing aluminum, calcium, iron, or
             magnesium

          -  History of vestibular incidents including vertigo, lightheadedness, nausea, or
             vomiting wit",439383,"Vertigo",FALSE
"NCT01698086","vertigo","us),
             peripheral vestibular disorders (unilateral/bilateral vestibular hypofunction: benign
             positional paroxysmal vertigo, Meniere's disease, acoustic neuroma)

          -  d",439383,"Vertigo",FALSE
"NCT00581659","vertigo","er implanted within last 6 months

          -  known seizure disorder or epilepsy

          -  Meniere's disease or any inner ear, vertigo, hearing, or balance conditions

          -  known narcole",439383,"Vertigo",FALSE
"NCT00938145","vertigo","f this trial.

          -  Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe
             vertigo when they are moved into the MR.

          -  Patients with sickle",439383,"Vertigo",TRUE
"NCT02252874","vertigo","ing them from
             training

          -  Having self reported vestibular or cerebellar dysfunction, history of vertigo or
             severe hearing loss

          -  Suffering from crippli",439383,"Vertigo",TRUE
"NCT00802893","vertigo","eart failure, atrial fibrillation, aortic valve disease,
             bleeding disorders, history of repeated syncope or vertigo, severe GERD, GI ulcer,
             symptomatic coronary or peripheral",439383,"Vertigo",TRUE
"NCT01950312","vertigo","n the past three
             years

          -  Hearing loss that coincides with significant, disabling episodes of vertigo

          -  History of allergic or anaphylactic reactions to monoclonal ",439383,"Vertigo",TRUE
"NCT01604408","vertigo","the investigator.

        Exclusion Criteria:

          -  Major lower limb pain or neurologic impairment or vestibular vertigo or visual
             impairment that could severely confound measure",439383,"Vertigo",TRUE
"NCT02046148","pre-eclampsia","
                  College of Obstetricians and Gynecologists guidelines (ACOG Practice Bulletin
                  2013)

               -  Pre-eclampsia or eclampsia as defined by American College of",439393,"Pre-eclampsia",FALSE
"NCT01487980","pre-eclampsia"," pregnancy

          2. history of postpartum haemorrhage (PPH)

          3. (gestational) diabetes

          4. pre-eclampsia

          5. abruptio placentae

          6. caesarian section

    ",439393,"Pre-eclampsia",FALSE
"NCT02411916","preeclampsia","e is polyhydramnios (amniotic fluid index >22 cm).

          -  Presence of acute or chronic renal disease

          -  Presence of preeclampsia

        Of subjects who enter the study, the develop",439393,"Pre-eclampsia",FALSE
"NCT01135758","preeclampsia","-  Treatment during the last 2 weeks with thyroid hormones and sympathicomimetic drug.

          -  Present or past diagnosis of eclampsia or preeclampsia.

          -  Untreated or insufficiently t",439393,"Pre-eclampsia",FALSE
"NCT03055390","preeclampsia","     4. Patients with indications of elective caesarean section.

          5. Medical conditions associated with pregnancy e.g. preeclampsia, diabetes mellitus.

          6. Contraindications for hy",439393,"Pre-eclampsia",FALSE
"NCT03070795","pre-eclampsia","n who require a Cesarean hysterectomy. Women who require a Post-partum hysterectomy.
        Mothers with severe pre-eclampsia. Mothers with sickle cell disease. Mothers with
        pregestational or",439393,"Pre-eclampsia",TRUE
"NCT01112891","pre-eclampsia","    -  History of previous adverse pregnancy outcome [preterm delivery <37; weeks GA,
             stillbirth, severe pre-eclampsia, eclampsia, HELLP syndrome (hemolytic anemia,
             elevated ",439393,"Pre-eclampsia",TRUE
"NCT03793153","preeclampsia","   -  Abruptio placenta, and placental abnormalities or accrete syndromes.

          -  Polyhydraminos, macrosomia, or preeclampsia.

          -  History of thromboembolic disorders, or severe anemi",439393,"Pre-eclampsia",TRUE
"NCT03360240","preeclampsia","r inclusion cases: Patients with pregnancy that starts before the age of 19
             that develops preeclampsia (mild), severe preeclampsia, gestational hypertension and
             eclampsia, th",439393,"Pre-eclampsia",TRUE
"NCT03824119","preeclampsia"," 20 weeks gestation

          -  Diagnosis of antenatal hypertensive disorder: gestational hypertension, preeclampsia
             without severe features, preeclampsia with severe features, superimp",439393,"Pre-eclampsia",TRUE
"NCT03238365","recurrent disease","y/paranasal sinuses, 6) unknown primary considered to have resectable
             disease; patients with recurrent disease that is amenable to surgery are eligible

          -  Eastern Cooperative O",440059,"Recurrent disease",FALSE
"NCT03967379","recurrent disease","using distress based on the NCCN
             survivorship guidelines

        Exclusion Criteria:

          -  Recurrent disease requiring treatment

          -  Significant uncontrolled psychiatri",440059,"Recurrent disease",FALSE
"NCT03370276","recurrent disease","          the first-line therapy. Additionally, patients with persistent disease or
             platinum-refractory recurrent disease may enroll in this study as a first-line
             therapy.

 ",440059,"Recurrent disease",FALSE
"NCT02010606","recurrent disease","nd pathology from the resection that qualifies
             the patient for the trial must be consistent with recurrent disease (ie, patients with
             predominantly pseudoprogression or radia",440059,"Recurrent disease",FALSE
"NCT00093626","recurrent disease","logically confirmed ovarian epithelial or primary peritoneal carcinoma

               -  Persistent or recurrent disease

          -  Measurable or evaluable disease

               -  Measurable di",440059,"Recurrent disease",FALSE
"NCT01701752","recurrent disease"," for the study.

          -  Women of child-bearing potential

          -  Clinically significant , uncontrolled, current, chronic or recurrent disease, as
             deemed by the Investigator, (",440059,"Recurrent disease",TRUE
"NCT02385630","recurrent disease","    7. History of significant food allergy, certain dietary restrictions

          8. Confirmed or suspected residual or recurrent disease after surgery, synchronous or
             metachronous mali",440059,"Recurrent disease",TRUE
"NCT00446849","recurrent disease","or severe renal impairment are contra-indicated for treatment
             with mesalamine compounds and are excluded from the study.

         14. Subjects with current or recurrent disease that coul",440059,"Recurrent disease",TRUE
"NCT00585377","recurrent disease","        elements are present, in which case the patient is ineligible.

          -  Stage wet IIIB-IV or recurrent disease

          -  No significant hemoptysis (bright red blood< 1/2 teaspoon or m",440059,"Recurrent disease",TRUE
"NCT01754285","recurrent disease","ally significant or relevant abnormal medical history, vital sign, physical
             examination, ECG, or laboratory evaluation finding

          8. Current or recurrent disease that could affect",440059,"Recurrent disease",TRUE
"NCT03474276","severe malnutrition","         -  Child able to be followed up during at least three months.

        Exclusion Criteria:

          -  Severe malnutrition defined by a mid upper arm circumference < 115 mm OR Weight/Height",440370,"Nutritional marasmus",FALSE
"NCT02835157","severe malnutrition","chronic kidney disease with baseline deranged renal function (eGFR
             < 90 ml/1.73 m2/min)

          -  Severe malnutrition

          -  Children whose parents refuse to give an informed c",440370,"Nutritional marasmus",FALSE
"NCT01734408","severe malnutrition","izures or progressive neurological disease

          -  Family history of congenital or hereditary immunodeficiency

          -  Severe malnutrition or dysgenopathy

          -  Major congenital de",440370,"Nutritional marasmus",FALSE
"NCT01549288","severe malnutrition","    will be obtained to look for inborn error of metabolism.

          -  Children with renal, pulmonary, cardiac or hepatic dysfunction

          -  Severe malnutrition (weight for length and heigh",440370,"Nutritional marasmus",FALSE
"NCT01399853","severe malnutrition"," history of seizures or progressive neurological disease

          -  Family history of congenital or hereditary immunodeficiency

          -  Severe malnutrition or dysgenopathy

          -  Major",440370,"Nutritional marasmus",FALSE
"NCT03170401","severe malnutrition","t for at least 1 week

        Exclusion Criteria:

          -  Significant chronic organ failure,

          -  severe malnutrition pre-existing prior to ICU admission

          -  not expected to ",440370,"Nutritional marasmus",TRUE
"NCT01115439","severe malnutrition","(WHO)

          -  Mixed or mono-infection with another Plasmodium species detected by microscopy

          -  Presence of severe malnutrition (defined as a child whose growth standard is below -3
 ",440370,"Nutritional marasmus",TRUE
"NCT04012333","severe malnutrition","h nutritional
             risk:

               1. Low (≤25) or High BMI (≥35)

               2. Moderate to severe malnutrition (as defined by local assessments). We will
                  document",440370,"Nutritional marasmus",TRUE
"NCT01399723","severe malnutrition","vere pneumonia

          -  Clinical or laboratory diagnosis of meningitis

          -  Clinical diagnosis of severe malnutrition (marasmus/kwashiorkor)

          -  Clinical or laboratory diagnosi",440370,"Nutritional marasmus",TRUE
"NCT03427307","severe malnutrition","with severe infections, severe heart disease and liver disease, malignancy,
             autoimmune disorders, severe malnutrition, or clinical conditions requiring oral
             nutrition supplem",440370,"Nutritional marasmus",TRUE
"NCT00326677","depression","Inclusion Criteria:

          -  Age 50 or greater

          -  Center for Epidemiological Studies of Depression Scale (CES-D) score of 11 or higher

          -  Folstein Mini-Mental State score of",440383,"Depressive disorder",FALSE
"NCT00352196","depression","
             medical condition, substance-induced psychotic disorder,psychotic disorder not
             otherwise specified, major depression with psychotic features, or bipolar disorder.

         ",440383,"Depressive disorder",FALSE
"NCT02395263","depression","(suicide assessment) of the HAMD.

          -  The subject has a current DSM-Ⅳ-TR axisⅠpsychiatric diagnosis other than depression.

          -  When the MADRS score of baseline visit compares with ",440383,"Depressive disorder",FALSE
"NCT00576355","depressed"," bipolar spectrum disorder: type I, type II, or NOS

          -  Currently meets DSM-IV criteria for a depressed, manic, hypomanic, or mixed episode

          -  Youth assent/parental consent to out",440383,"Depressive disorder",FALSE
"NCT02100982","depression"," diabetes, heart
             disease, arthritis, asthma, COPD

          -  positive screen for symptoms of depression and/or anxiety

        Exclusion Criteria:

          -  non-English speakers

",440383,"Depressive disorder",FALSE
"NCT04010149","depression","-report (e.g., anxiety disorder,
             ADHD, Parkinson's disease, etc.)

          2. History of diagnosed severe depression (diagnosed pre-injury)

          3. History of epilepsy (diagnosed ",440383,"Depressive disorder",TRUE
"NCT00000444","depression","onality
             disorder.

          -  Unable to participate in protocol due to functional deficits or severe depression.

          -  Suicidal or homicidal ideation.

          -  Current use ",440383,"Depressive disorder",TRUE
"NCT01329913","depression"," major neurological disorder, or uncontrolled
             clinically significant psychiatric disorder (for example, depression).

          -  Estimated creatinine clearance of ≤70 mL/min.

         ",440383,"Depressive disorder",TRUE
"NCT01128816","depression","it unlikely that
             the patient will comply with the study procedures (e.g. alcohol abuse, lack of
             permanent residence, severe depression, disorientation, distant location, or h",440383,"Depressive disorder",TRUE
"NCT00302367","depression","Right handed.

        Exclusion Criteria:

          1. Diagnosis of any psychotic disorder, bipolar disorder, severe depression, severe
             anxiety, or Autism. Subjects with mild mood, oppo",440383,"Depressive disorder",TRUE
"NCT03893097","anxiety disorder","ory of, or ongoing, epilepsy or psychiatric illness (I.e. recent history of
             depression, generalized anxiety disorder; history of psychosis, schizophrenia or other
             major psych",442077,"Anxiety disorder",FALSE
"NCT01237587","anxiety disorder","(DSM-IV)
             Axis I condition, currently or within the past year, except major depressive disorder
             (MDD) and/or generalized anxiety disorder (GAD), adjustment disorder or specifi",442077,"Anxiety disorder",FALSE
"NCT03406845","anxiety disorder","is, with depression (Patient Health
             Questionnaire (PHQ-9) score ≥6) and/or anxiety (General Anxiety Disorder-7 (GAD- 7)
             score ≥6).

          -  Normal cognition or Mild Cogn",442077,"Anxiety disorder",FALSE
"NCT00277654","anxiety disorder"," Fourth Edition (DSM-IV) criteria.

          3. Subjects must have lifetime panic disorder or generalized anxiety disorder (GAD) as
             defined by DSM-IV criteria (except clause ""does not oc",442077,"Anxiety disorder",FALSE
"NCT01426997","anxiety disorder","MMSE)unless otherwise approved by
             principle investigator

          -  meets criteria for schizophrenia (Given overlap of generalized anxiety disorder (GAD)
             with major depres",442077,"Anxiety disorder",FALSE
"NCT01966705","anxiety disorder","     -  A primary diagnosis of severe health anxiety (somatic symptom disorder or illness
             anxiety disorder) according to the Diagnostic and Statistical Manual of Mental
             Disor",442077,"Anxiety disorder",TRUE
"NCT04086342","anxiety disorder","ter A or B);

          4. Current moderate or severe major depressive episode, panic disorder, generalized
             anxiety disorder, or post-traumatic stress disorder (PTSD). Traits associated w",442077,"Anxiety disorder",TRUE
"NCT03478384","anxiety disorder","vere, life-threatening, or prognostic unfavorable comorbidities

          9. Pregnancy, lactation

         10. Indication of a severe depression/anxiety disorder at baseline (PHQ 9 Score ≥15 and/or
",442077,"Anxiety disorder",TRUE
"NCT00550667","anxiety disorder",", organic
             psychosis, schizotypal personality disorder, bipolar affective disorder, severe
             anxiety disorder(such as OCD, ASD or PTSD) and mental retardation.

          -  In ",442077,"Anxiety disorder",TRUE
"NCT00458445","anxiety disorder","          (PTSD), psychosis, bipolar illness, severe obsessive compulsive disorder, severe
             depressive or severe anxiety disorder or other symptomatic manifestations that, in the
         ",442077,"Anxiety disorder",TRUE
"NCT02074644","lower urinary tract symptoms","PSA

          -  Use of a marketed alpha-blocker for LUTS/BPH in the previous 6 months

          -  Severe lower urinary tract symptoms at screening and baseline defined by all the
             foll",443350,"Lower urinary tract symptoms",FALSE
"NCT03576001","lower urinary tract symptoms","ls with a contraindication for androgen use:

               -  History of prostate or breast cancer

               -  Severe lower urinary tract symptoms (IPSS score of > 19)

               -  Pros",443350,"Lower urinary tract symptoms",FALSE
"NCT00827242","lower urinary tract symptoms","ars of age or older with Benign Prostatic Hyperplasia (BPH) also referred to
             as BPH-LUTS [lower urinary tract symptoms] based on the disease diagnostic criteria at
             the start ",443350,"Lower urinary tract symptoms",FALSE
"NCT01738464","lower urinary tract symptoms","tis/painful bladder syndrome (IC/PBS), chronic prostatitis/chronic
             pelvic pain syndrome (CP/CPPS), Lower Urinary Tract Symptoms, Overactive Bladder, or
             Major Depression.

   ",443350,"Lower urinary tract symptoms",FALSE
"NCT00239161","lower urinary tract symptoms","ys) of costovertebral angle pain or tenderness with or
             without fever, and with or without lower urinary tract symptoms (dysuria, frequency,
             urgency). Diabetic women without l",443350,"Lower urinary tract symptoms",FALSE
"NCT02135341","lower urinary tract symptoms","          consent form

        Exclusion Criteria:

          -  Use of antimuscarinic agent and effective in treatment of lower urinary tract symptoms

          -  Patients with severe cardiopulmon",443350,"Lower urinary tract symptoms",TRUE
"NCT01748370","lower urinary tract symptoms","pable prostate nodule or induration

          -  Hematocrit >50%

          -  Untreated severe obstructive sleep apnea

          -  Severe lower urinary tract symptoms

          -  Uncontrolled or",443350,"Lower urinary tract symptoms",TRUE
"NCT01505075","lower urinary tract symptoms","ibility of gold seeds on electronic portal imaging)

          -  large prostate (> 90cm3) on imaging

          -  severe lower urinary tract symptoms (International Prostate Symptom Score >19 or
   ",443350,"Lower urinary tract symptoms",TRUE
"NCT04032067","lower urinary tract symptoms","erplasia

               1. A volume of prostate gland (TRUS) > 30 cc

               2. Moderate to severe lower urinary tract symptoms with IPSS ≥ 13

               3. 5-15 mL/sec of maximum flow r",443350,"Lower urinary tract symptoms",TRUE
"NCT01657409","lower urinary tract symptoms","e hospital.

        Exclusion Criteria:

          -  Use of antimuscarinic agent and effective in treatment of lower urinary tract symptoms

          -  Patients with severe cardiopulmonary disease",443350,"Lower urinary tract symptoms",TRUE
"NCT01881516","cognitive dysfunction","SCLC;

          -  ECOG 3~4;

          -  Pregnant woman;

          -  >65 or <18 years old;

          -  Patients with evidence of any cognitive dysfunction that would limit their abilities
     ",443432,"Impaired cognition",FALSE
"NCT02265848","cognitive impairment","         3. Subject pain scores >5 on NPRS

        Exclusion Criteria:

          1. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that
             would limit study",443432,"Impaired cognition",FALSE
"NCT02051608","cognitive deficit","       -  History or presence of systemic autoimmune disorders potentially causing progressive
             neurologic disease with associated cognitive deficits

          -  History of schizophrenia",443432,"Impaired cognition",FALSE
"NCT04077541","cognitive dysfunction","ne and access to the Internet

        Exclusion Criteria:

          -  Discharged within 24 hours

          -  Cognitive dysfunction and unable to provide formal consent

          -  Severe brain ",443432,"Impaired cognition",FALSE
"NCT01301040","cognitive dysfunction","ancer diagnosis of the patients to be fit enough to complete
                  the questionnaires

               -  to be French speaking

               -  to be free of any cognitive dysfunction.

",443432,"Impaired cognition",FALSE
"NCT00079807","cognitive impairment","cologic treatment for 12 weeks prior to
             enrollment

        Exclusion Criteria:

          -  Any significant cognitive impairment or psychosis

          -  Pregnancy or anticipated preg",443432,"Impaired cognition",TRUE
"NCT03720821","cognitive impairment","          -  Lack of email/lack of basic computer skills

          -  Diagnosed Alzheimer's or documented severe cognitive impairment

          -  Severely impaired vision or color blindness

      ",443432,"Impaired cognition",TRUE
"NCT00937001","cognitive deficit","nown brain lesions, traumatic brain
             injury, cerebrovascular accidents with resultant moderate to severe cognitive deficits
             or ADL dependency, Parkinson's disease, Huntington'",443432,"Impaired cognition",TRUE
"NCT00283881","cognitive deficit","erebellum or brainstem,

          -  have a history of alcohol or drug abuse or severe language disturbances or serious
             cognitive deficits,

          -  have uncontrolled medical proble",443432,"Impaired cognition",TRUE
"NCT03393351","cognitive impairment","ears

          -  German-speaking

        Exclusion Criteria for participating patients:

          -  severe cognitive impairment

        Inclusion Criteria for participating health care professio",443432,"Impaired cognition",TRUE
"NCT03178006","acute disease","ween 18-24.9 kg / m2 without diabetes or altered glucose tolerance

        Exclusion Criteria:

          -  Acute disease

          -  Chronic pulmonary, cardiovascular, haematological, gastrointes",443883,"Acute disease",FALSE
"NCT03701438","acute disease","ccine including egg and chicken
             protein, or history of hypersensitivity to a previous dose of an influenza vaccine

          -  Acute disease and/or fever at the time of baseline blood d",443883,"Acute disease",FALSE
"NCT01106092","acute disease"," -  collapse or shock-like state within 48 hours of vaccination,

               -  convulsions with or without fever, occurring within 3 days of vaccination.

          -  Acute disease and/or fever ",443883,"Acute disease",FALSE
"NCT00001464","acute disease","NCLUSION CRITERIA:

        History - good overall health without history of recent (within 3 months) acute disease;

        Physical examination within normal limits;

        Laboratory evaluation;",443883,"Acute disease",FALSE
"NCT02838914","acute disease","up tests and evaluation procedures.

          4. Aged 18-80 years.

        Exclusion Criteria:

          1. With acute diseases, such as acute phase after myocardial infarction (within 3
          ",443883,"Acute disease",FALSE
"NCT02888418","acute disease","r or kidney disease, cardiovascular disease, severe
             hypertension, diabetes, cancer, all kinds of infectious disease and acute disease or
             in acute attack period of chronic dis",443883,"Acute disease",TRUE
"NCT00287469","acute disease","
          -  Major congenital defects or serious chronic illness.

          -  History of any neurologic disorders or seizures.

          -  Acute disease at the time of enrollment. Acute disease w",443883,"Acute disease",TRUE
"NCT02981836","acute disease","Severe malnutrition, congenital malformation, developmental disorders, or serious
             chronic diseases;

          -  Acute disease or acute stage of chronic disease within 7 days prior to st",443883,"Acute disease",TRUE
"NCT01218308","acute disease","ine; or a history of severe adverse
             reaction to a previous influenza vaccine.

          -  Fever at the time of enrolment.

          -  Acute disease at the time of enrolment.

        ",443883,"Acute disease",TRUE
"NCT02009748","acute disease","min/1.73m²

          -  Any disease with an estimated life expectancy below 1 year

          -  Any clinically significant acute disease requiring drug treatment

          -  Anticipated chemothera",443883,"Acute disease",TRUE
"NCT03679000","genetic disease","        -  Congenital azoospermia

               -  Ejaculation dysfunction

               -  Family history of genetic diseases

          4. Acquired diseases

               -  Genitourinary infe",443916,"Hereditary disease",FALSE
"NCT02917863","genetic disease","    -  Patients with celiac disease, type I diabetes or other known autoimmune diseases

          -  Patients with genetic diseases or syndromes, such as Down, Williams-Beuren, Turner

          -  A",443916,"Hereditary disease",FALSE
"NCT01703728","genetic disease"," to the use of gonadotropins or current pregnancy diagnosed by the
             clinician.

          -  Recurrent miscarriages, known genetic disease of one of the partners or indication of
         ",443916,"Hereditary disease",FALSE
"NCT02975986","genetic disease"," SPECT/CT, pregnancy, breastfeeding, chronic renal disease (eGFR <
             60 ml/min/1.73m2), proteinuria, genetic diseases of the kidney, inborn defects of
             lipid metabolism, alcohol",443916,"Hereditary disease",FALSE
"NCT01925196","hereditary disease","tion, such as structural brain or spinal cord disease, metabolic
             diseases, paraneoplastic syndromes, hereditary diseases, infectious diseases,
             peripheral neuropathy or radicu",443916,"Hereditary disease",FALSE
"NCT00635258","genetic disease","r hepatitis B and C, human
             immunodeficiency viruses I and II, syphylis, and vaginal infection), genetic disease,
             severe endometriosis or pelvic inflamatory disease

         ",443916,"Hereditary disease",TRUE
"NCT00646893","genetic disease","nancy;

          -  Prior severe OHSS;

          -  TESA and TESE patients;

          -  Patients carriers of chromosomal or genetic diseases.

          -  Egg donation cycles.

          -  Froze",443916,"Hereditary disease",TRUE
"NCT01050075","inherited disease","nced any peripheral neuropathy prior to chemotherapy

          -  Patients who have the potential for serious bleeding due to inherited diseases such as
             hemophilia

          -  Patients",443916,"Hereditary disease",TRUE
"NCT00841295","genetic disease","lusion Criteria:

          -  Severe associated disorder, with a probable short-term death,

          -  Identified genetic disease,

          -  Polymalformative syndrome, or severe malformation (",443916,"Hereditary disease",TRUE
"NCT01469273","genetic disease","    -  Severe co-morbidities diseases of the:

               -  Heart

               -  Liver

               -  Kidney

          -  Genetic disease

          -  Other serious associated diseases,",443916,"Hereditary disease",TRUE
"NCT00257075","affective disorder","MADRS) at start of the study

        Exclusion Criteria:

          -  Patients who meet DSM-IV criteria for Schizoaffective Disorder or for rapid cycling

          -  with borderline or antisocial ",444100,"Mood disorder",FALSE
"NCT00001247","affective disorder","          -  Age 18 or older

          -  Male or female

          -  Diagnosis of Schizophrenia, Schizoaffective Disorder or Psychosis NOS. Subjects with
             other neuropsychiatric disorde",444100,"Mood disorder",FALSE
"NCT01945333","affective disorder","     1. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or
             schizoaffective disorder

          2. Age 18 to 65

          3. English speaking

          4. Psychi",444100,"Mood disorder",FALSE
"NCT00271258","affective disorder","stablished or known mental retardation

               -  Autistic disorders

               -  Established schizophrenia

               -  Schizoaffective disorders

          -  Somatic criteria:

",444100,"Mood disorder",FALSE
"NCT00405535","affective disorder","

          -  Active substance use disorder within the last 6 months

          -  Comorbid schizophrenia, schizoaffective disorder, bipolar disorder, tic disorder,
             Tourette Disorder, sc",444100,"Mood disorder",FALSE
"NCT03801096","affective disorder","and/or severe psychiatric disorder that would interfere with
             participation (i.e., Schizophrenia, Delusional Disorder, Schizoaffective Disorder,
             Bipolar Disorder, or a Mood Di",444100,"Mood disorder",TRUE
"NCT01771627","affective disorder","reated for a mental health problem like
                  major depression, bipolar disorder, dysthymia, or schizoaffective disorder?""

               -  ""Have you ever had serious thoughts of killing",444100,"Mood disorder",TRUE
"NCT00459550","affective disorder","ndication to lumbar puncture.

          -  History or evidence of significant psychiatric illness such as schizophrenia or
             bipolar affective disorder or significant neurological disease ",444100,"Mood disorder",TRUE
"NCT03172533","affective disorder","resent alcohol or drug abuse

          -  severe psychiatric disorders (axis I) according to the DSM V (such as bipolar
             affective disorder or schizophrenia) in addition to anorexia nervo",444100,"Mood disorder",TRUE
"NCT03345953","mood disorder","        -  Any significant psychiatric illness (schizophrenia, bipolar disorder, severe
             depression, dementia, obsessive compulsive disorder...) or mood disorder, assessed by
             ",444100,"Mood disorder",TRUE
"NCT00831220","inflammatory disease","o needed invasive or non invasive mechanical
             ventilation

          -  Patients with other chronic inflammatory diseases.

          -  Patients with other acute or active chronic systemi",4027384,"Inflammatory disorder",FALSE
"NCT00685373","inflammatory disease","amilial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome or
             Neonatal Onset Multisystem Inflammatory Disease. Prior agreement between the
             Investigator and Novartis for st",4027384,"Inflammatory disorder",FALSE
"NCT02767154","inflammatory disorder","  Ongoing septicaemia

          -  Ongoing antithrombotic treatment other than acetylsalicylic acid

          -  Systemic inflammatory disorders treated with corticosteroids

          -  Not able t",4027384,"Inflammatory disorder",FALSE
"NCT00737282","inflammatory disease"," or expecting to become
             pregnant at any time during the study;

          -  Documented endometriosis, active pelvic inflammatory disease (PID), platelet
             dysfunction, or Von ",4027384,"Inflammatory disorder",FALSE
"NCT03917277","inflammatory disease","          -  Age ≥ 18 years old

          -  Patient followed by the National reference center for autoinflammatory diseases and
             inflammatory amyloidosis (CeRéMAIA) at Tenon Hospital in ",4027384,"Inflammatory disorder",FALSE
"NCT01255956","inflammatory disease","ntrast

          -  other diseases that may cause significant deterioration in long-term prognosis

          -  acute or chronic inflammatory diseases

          -  patients who are unwilling to con",4027384,"Inflammatory disorder",TRUE
"NCT03304951","inflammatory disease","r active pus from nose.

          -  Any sign of active ophthalmic disease, infection or inflammation including the
             presence of severe ocular surface inflammatory disease as determined b",4027384,"Inflammatory disorder",TRUE
"NCT00443339","inflammatory disease","ia

          -  Creatinine level > 120% upper normal value for the center.

          -  Clinically significant systemic infection or chronic inflammatory disease (eg,
             rheumatoid arthrit",4027384,"Inflammatory disorder",TRUE
"NCT00596219","inflammatory disease","       -  History of acute or chronic hepatic disorder or a significant bleeding disorder.

          -  History of chronic inflammatory disease (e.g. ulcerative colitis, Crohn's
             disease,",4027384,"Inflammatory disorder",TRUE
"NCT03807167","inflammatory disorder","rs) criteria).

          -  Other neurological conditions (stroke, Parkinson's disease and seizures), severe and
             inflammatory disorders (ex: severe arthroses which limits movements, spon",4027384,"Inflammatory disorder",TRUE
"NCT02255201","seizure disorder","           -  bipolar disorder

               -  pulmonary disease (including current asthma)

               -  Parkinson's disease

               -  Seizure disorder

               -  unstable th",4029498,"Seizure disorder",FALSE
"NCT00953199","seizure disorder","   Exclusion Criteria:

          -  Known sensitivity to lidocaine or contrast agent

          -  History of seizure disorder

          -  History of cardiac arrhythmia (tachyarrhythmia, bradyarrhy",4029498,"Seizure disorder",FALSE
"NCT03577171","seizure disorder","ic agents,
             neuromuscular, musculoskeletal, or mucocutaneous conditions requiring frequent
             treatment, seizure disorders requiring treatment, or other medical conditions
      ",4029498,"Seizure disorder",FALSE
"NCT00118482","seizure disorder","Another clinical need for fludrocortisone that cannot be met with other drugs

          -  A permanent pacemaker

          -  A seizure disorder

          -  A major chronic non cardiovascular dise",4029498,"Seizure disorder",FALSE
"NCT01064401","seizure disorder","g or alcohol abuse (as defined by the Investigator) within the 2 years
             prior to randomization

          -  History of seizure disorder or unexplained blackouts OR history of a seizure wi",4029498,"Seizure disorder",FALSE
"NCT01279538","seizure disorder"," Subject has uncontrolled intercurrent illness, including, but not limited to ongoing
             or active infection, any clinically significant cardiac disease, seizure disorder, or
             ps",4029498,"Seizure disorder",TRUE
"NCT00070343","seizure disorder","
          -  Negative pregnancy test

          -  Fertile patients must use effective contraception

          -  No other significant medical disease

          -  No uncontrolled seizure disorder
",4029498,"Seizure disorder",TRUE
"NCT02028455","seizure disorder","umented in order to be eligible.

        Patients must NOT have active clinically significant CNS dysfunction (including but not
        limited to such as uncontrolled seizure disorder, paresis, aph",4029498,"Seizure disorder",TRUE
"NCT00847600","seizure disorder","clusion Criteria:

          1. Evidence of serious neurologic or endocrine disorder, for example severe head trauma,
             seizure disorder, dementia, Cushings disease, or thyroid disorder, me",4029498,"Seizure disorder",TRUE
"NCT03343626","seizure disorder","ng excipients of the investigational vaccine or placebo).

          4. Has any history of progressive or severe neurologic disorder, seizure disorder or
             neuro-inflammatory disease (examp",4029498,"Seizure disorder",TRUE
"NCT02152566","left ventricular systolic dysfunction","       -  Heart Failure from ischemic or non-ischemic dilated cardiomyopathy for ≥ 6 months

          -  Left ventricular systolic dysfunction (LVEF ≤45% by echocardiography performed within
        ",4047088,"Left ventricular systolic dysfunction",FALSE
"NCT01520610","left ventricular systolic dysfunction","associated with ST-segment abnormalities and/or increased
             serum troponin level, 2) transient left ventricular systolic dysfunction, and 3) no
             coronary lesions related to the ",4047088,"Left ventricular systolic dysfunction",FALSE
"NCT01320007","left ventricular systolic dysfunction","vol capable Device

          -  Previous hospital admission for decompensated heart failure

          -  Left ventricular systolic dysfunction (EF <50%)

          -  Currently compensated heart fai",4047088,"Left ventricular systolic dysfunction",FALSE
"NCT00409578","left ventricular systolic dysfunction","          chemical structures.

          -  Presence of clinically overt heart failure

          -  Known evidence of left ventricular systolic dysfunction

          -  Percutaneous coronary interv",4047088,"Left ventricular systolic dysfunction",FALSE
"NCT01012414","left ventricular systolic dysfunction","     hyperphosphatemia (≥ 5.5 mg/dL)

          -  Plan to initiate renal replacement therapy (dialysis) during the study

          -  History of left ventricular systolic dysfunction with an ejectio",4047088,"Left ventricular systolic dysfunction",FALSE
"NCT03470207","left ventricular systolic dysfunction",". The patient previously met diagnostic criteria for pulmonary hypertension of any cause.

        ii. Presence of significant left ventricular systolic dysfunction (defined by left
        ventricula",4047088,"Left ventricular systolic dysfunction",TRUE
"NCT02291237","left ventricular systolic dysfunction","
          -  Known aortic valve stenosis (moderate or severe)

          -  Known coronary artery disease

          -  Left ventricular systolic dysfunction (ejection fraction < 50%)

          -  R",4047088,"Left ventricular systolic dysfunction",TRUE
"NCT01387191","left ventricular systolic dysfunction","       -  Subjects with right cardiac failure during an acute exacerbation

          -  Subjects with severe left ventricular systolic dysfunction

          -  Subjects with serious left ventricular",4047088,"Left ventricular systolic dysfunction",TRUE
"NCT01572220","left ventricular systolic dysfunction","ical
                       criteria

                    -  Acute decompensated congestive heart failure

                    -  Established severe left ventricular systolic dysfunction (left ventric",4047088,"Left ventricular systolic dysfunction",TRUE
"NCT00641134","left ventricular systolic dysfunction","aine >IIb), metastatic cancer)

          -  Symptomatic (NYHA II-IV) chronic heart failure

          -  Moderate-to-severe left ventricular systolic dysfunction (left ventricular ejection
          ",4047088,"Left ventricular systolic dysfunction",TRUE
"NCT03368950","disability","ng at the time of
             study

          -  Actively psychotic, having received a diagnosis of dementia or a learning disability

          -  Severe mental health difficulties based on judgeme",4052648,"Disability",FALSE
"NCT03589014","disability"," events: intracerebral hemorrhage, stroke, permanent or
             transient focal deficits, seizures, disability or any other neurological symptom
             supposedly related to CCM;

         ",4052648,"Disability",FALSE
"NCT03732053","disability","s Disease

          -  Older than 40 years of age

          -  Male and female

          -  Intellectual disability

          -  Cognitive impairment

          -  Able to do daily activities on h",4052648,"Disability",FALSE
"NCT00196573","disability","s of conservative treatment. Failed conservative treatment will be
             defined as persistent pain and disability despite adequate non-operative management
             for 6 months. Non-opera",4052648,"Disability",FALSE
"NCT01039103","disability","o only have optic neuritis
             will be excluded from this study

          -  A maximum Expanded Disability Status Scale (EDSS) score of ≤ 6

          -  New neurological symptoms or exacerb",4052648,"Disability",FALSE
"NCT03826238","disability","        -  abstinent during 15 to 90 days according to self-reports

          -  no severe upper limb motor disability.

          -  Older than 18 years old.

          -  abìlity to talk, understan",4052648,"Disability",TRUE
"NCT02119533","disability","ave both eyes in order for
             the eye tracking data to be effective and significant.

          -  Any physical or mental injury or baseline disability rendering task completion
            ",4052648,"Disability",TRUE
"NCT00833989","disability","eria:

          -  History of a previous symptomatic stroke within 3 months prior to study entry.

          -  Presence of significant disability prior to the current stroke. Significant disability
",4052648,"Disability",TRUE
"NCT02337244","disability","sty based on physical exam and
             medical history, including diagnosis of severe knee pain and disability due to at
             least one of the following:

               -  rheumatoid art",4052648,"Disability",TRUE
"NCT00106886","disability"," patient's ability to complete the study, such as: *history of alcohol or
             drug abuse, *psychiatric disorders, *senility, *severe physical disability, *illnesses
             including ter",4052648,"Disability",TRUE
"NCT01684293","learning disorder","      hospitalization

          7. Currently symptomatic from attention-deficit/hyperactivity disorder (DSM-5 criteria)

          8. Any learning disorder, any type of dementia, any type of delirium",4085156,"Developmental academic disorder",FALSE
"NCT00778310","learning disorder"," Concerta (OROS-methylphenidate)

        Exclusion Criteria:

          -  IQ < 95

          -  Presence of Learning Disorder

          -  Presence of an Affective or Psychotic Disorder

          ",4085156,"Developmental academic disorder",FALSE
"NCT02349529","learning disability","roup process

          -  In mainstream schooling.

        Exclusion Criteria:

          -  Formal diagnosis of Learning Disability or attendance at a school for children with
             Special ",4085156,"Developmental academic disorder",FALSE
"NCT03018574","learning disorder","             developmental disorder (autism), bipolar disorder, psychosis, language difficulties or
             learning disorders (reading disorders, mathematics disorders and disorders of written
 ",4085156,"Developmental academic disorder",FALSE
"NCT01730209","learning disability","-  With an IQ estimated <80 and/or special schooling and/or autism spectrum disorder
             and/or learning disability requiring remedial teaching.

          -  Written informed consent by pare",4085156,"Developmental academic disorder",FALSE
"NCT03695068","learning disorder","participant participates in an alternative curriculum (i.e., life skills
             course) due to moderate to severe learning disorders.

          -  The potential participant received a score of ",4085156,"Developmental academic disorder",TRUE
"NCT00252980","learning disability","  current severe episode of Major depression

          -  current panic-agoraphobic disorder (severe)

          -  severe learning disability, brain damage or pervasive developmental disorder

     ",4085156,"Developmental academic disorder",TRUE
"NCT03287362","learning disability","tic or bipolar disorder

          4. severe neurological or internal concomitant diseases

          5. IQ < 80; severe learning disability, brain damage or pervasive developmental disorder

        ",4085156,"Developmental academic disorder",TRUE
"NCT01378455","learning disability","ers.

          -  significant hearing or visual impairment

          -  significant sensory impairment.

          -  Learning disability

          -  Test of Nonverbal Intelligence( TONI-2) less t",4085156,"Developmental academic disorder",TRUE
"NCT03857347","learning disability","riencing active severe psychiatric symptoms

          -  A dependency on alcohol or recreational drugs

          -  Learning disability as classified by ICD 10.

          -  Those unable to travel ",4085156,"Developmental academic disorder",TRUE
"NCT02331459","frailty","rs old and older

          3. Frail geriatric patient according to the Cardiovascular Health Study (CHS) Frailty
             Phenotype

          4. Gait speed less than 0.8 m/s.

        Exclusion ",4086506,"Frailty",FALSE
"NCT03949439","frailty"," (previous stroke or muscular dystrophies), cognitive
             impairment resulting from previous injury, frailty score ≥ 5, non-elective/emergency
             surgery procedures or incomplete da",4086506,"Frailty",FALSE
"NCT03865095","frailty","  mechanical ventilation expected for at least 48 hours

        Exclusion Criteria:

          -  Clinical Frailty Score above 7 prior admission

          -  neuromuscular disease in previous medica",4086506,"Frailty",FALSE
"NCT03393754","frailty","rmined by the investigator, and not meeting
             the exclusion criteria. For subjects > 65 years old, Frailty Index ≤3

          -  If female, either is not of childbearing potential or is of",4086506,"Frailty",FALSE
"NCT02975089","frailty","usion Criteria:

          -  ≥ 65 years of age

          -  Have at least one of the modified Fried's Frailty phenotypes

          -  Sign informed consent form for study participation

        Mod",4086506,"Frailty",FALSE
"NCT02952443","frailty","f age

          -  Free of any serious injury in the last 6 months

          -  Deemed to express the pre-frailty phenotype, meaning they are classified as: Pre-frail
             according to the C",4086506,"Frailty",TRUE
"NCT04038294","frailty","evere regurgitation or
             combined CABG/valve procedures.

          2. Patients with a Clinical Frailty Score (CFS) from 3 (Managing Well) to 7 (severely
             frail),

          3. ",4086506,"Frailty",TRUE
"NCT03458793","frailty","cognitive disability or clinical diagnosis of dementia;

          6. physical disability (i.e. SPPB score less than 9);

          7. severe frailty or any chronic health condition that precludes par",4086506,"Frailty",TRUE
"NCT03971500","frailty","on likely to interfere with study processes including medication compliance
             or follow-up visits (e.g. dementia, alcohol abuse, severe frailty, long distance to
             travel for fol",4086506,"Frailty",TRUE
"NCT00193011","frailty","

          -  Age 65 or older

          -  Under age 65 must have significant medical illness, or general frailty

          -  Adequate bone marrow, liver or kidney function

          -  Normal he",4086506,"Frailty",TRUE
"NCT04123119","malnutrition","ipation in another clinical trial throughout the entire timeframe for
             this study

          -  Presence of malnutrition or any systemic disorder (cardiovascular, pulmonary, hepatic,
     ",4090739,"Nutritional disorder",FALSE
"NCT01817634","malnutrition","ria:

          -  Singleton infants

          -  6-12 months old

          -  Not suffering from acute malnutrition (wasting): WHZ > -2 , no edema

          -  Infants currently being breastfed

 ",4090739,"Nutritional disorder",FALSE
"NCT03301311","malnutrition","       -  Hospitalization or surgery planned within 3 months

          -  Ongoing active gastrointestinal infection

          -  Severe Malnutrition (BMI less than 5th percentile)

          -  Rece",4090739,"Nutritional disorder",FALSE
"NCT02130089","malnutrition"," interdialytic parenteral nutrition

          -  Transfer to another facility expected within 3 months

          -  Severe malnutrition, as assessed by Subjective Global Assessment (SGA) or other
  ",4090739,"Nutritional disorder",FALSE
"NCT03915366","malnutrition"," 24 hours

                    -  Lethargic or unconscious

                    -  Stridor while calm

                    -  Severe malnutrition

          4. HIV-confirmed infection (with at least o",4090739,"Nutritional disorder",FALSE
"NCT03897673","malnutrition","mptoms like persistent vomiting, high temperature
             (>39.5°C), or tea-colored urine

          -  Severe malnutrition, as evidenced by severe wasting or bilateral pitting edema

          -",4090739,"Nutritional disorder",TRUE
"NCT03762564","malnutrition","ients curatively
             treated and disease-free for at least 5 years will be discussed with the sponsor
             before inclusion.

          2. Patients with significant malnutrition who r",4090739,"Nutritional disorder",TRUE
"NCT02051881","nutritional disease","psies:

          1. History of severe cardiovascular, gastrointestinal/ hepatic,
             hematological/immunologic, metabolic/nutritional disease and/or laboratory assessments
             which",4090739,"Nutritional disorder",TRUE
"NCT00003394","malnutrition"," attack or
        stroke within 6 months Neurologic: No grade 3-4 peripheral neuropathy Other: No severe
        infection No severe malnutrition No other serious medical illnesses

        PRIOR CON",4090739,"Nutritional disorder",TRUE
"NCT03108131","malnutrition","least 7 days prior to enrollment)

          -  Uncontrolled intercurrent illness including, but not limited to diabetes,
             hypertension, severe infection, severe malnutrition, unstable ang",4090739,"Nutritional disorder",TRUE
"NCT03811626","multiple injuries","ated upon arrival at hospital

          -  Patient with injury to the medulla and with neurological signs or multiple injuries
             (at least 1 of which is life-threatening)

          -  Bra",4096313,"Multiple injuries",FALSE
"NCT03128086","multiple injuries","uromuscular disease,

          -  Spinal cord injury,

          -  Tracheostomy,

          -  Inability to be evaluated,

          -  Severe multiple injuries evaluated by the Injury Severity Scor",4096313,"Multiple injuries",FALSE
"NCT01754610","multiple trauma","ildren aged 1 through 17 years old at the time of recruitment

          -  Child and family exposed to multiple traumas

          -  a partial diagnosis of PTSD (15-week treatment version)

        ",4096313,"Multiple injuries",FALSE
"NCT01007006","multiple trauma","ish language for written and oral communication

          -  Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI),
             Post Traumatic Stress Disorder (PTSD) o",4096313,"Multiple injuries",FALSE
"NCT01672658","multiple trauma","han moderate
             assistance from the physical therapist/researcher.

        Exclusion Criteria:

          -  Multiple trauma

          -  Severe brain injury as defined above

          - ",4096313,"Multiple injuries",FALSE
"NCT03312348","multiple injuries","nt and carer consenting to
             participate.

        Exclusion Criteria:

          -  Children with multiple injuries (e.g. those involved in serious car accidents), or
             those wh",4096313,"Multiple injuries",TRUE
"NCT00547638","multiple trauma","
          -  patient is reasonably expected to survive the study

        Exclusion Criteria:

          -  significant multiple trauma (merely multiple wounds are allowed)

          -  peripheral v",4096313,"Multiple injuries",TRUE
"NCT04090424","multiple trauma","een experienced by the subject including soft-tissue
             degloving and friction burn/crush, i.e., road rash

          3. Multiple traumas, i.e., significant traumatic injury to a solid organ",4096313,"Multiple injuries",TRUE
"NCT01715012","multiple trauma","year.

          -  Patients requiring care in the Intensive Care Unit.

          -  Inhalation injury requiring mechanical ventilation.

          -  Multiple trauma (significant traumatic injury to",4096313,"Multiple injuries",TRUE
"NCT03919422","multiple trauma","ction or anticoagulation therapy

          4. History of upper limb nerve injury or phrenic nerve injury

          5. Multiple trauma

          6. Uncontrolled respiratory disease (severe chronic o",4096313,"Multiple injuries",TRUE
"NCT00936936","carrier"," as brain or
             meningeal metastases that are not in complete remission.

          6. Patients with active hepatitis B, either active carrier (HBsAg +) or viremic (HBV DNA
             >/=1",4106092,"Carrier of disorder",FALSE
"NCT03579927","carrier","rior therapy that has not resolved to </=
             G1.

          3. Prior whole brain irradiation.

          4. Active hepatitis B, either active carrier (HBsAg +) or viremic (HBV DNA >/= 10,000",4106092,"Carrier of disorder",FALSE
"NCT03805243","carrier","ases a headache);

          -  Use of the device(plan) within the framework of a resuscitation or of intensive care;

          -  Participating carrier of a defibrillator, a stimulating of the vagus",4106092,"Carrier of disorder",FALSE
"NCT00101959","carrier","     are of childbearing potential.

          -  The small minority of subjects for whom Rebif therapy is not reimbursed by their
             insurance carrier may be considered for the study if oth",4106092,"Carrier of disorder",FALSE
"NCT03062410","carrier","toxicities or adverse events.

          -  HIV positive.

          -  History of active chronic hepatitis including subjects who are carriers of Hepatitis B
             virus or Hepatitis C virus

",4106092,"Carrier of disorder",FALSE
"NCT00001765","carrier"," (normal blood count,
        normotensive, no history of stroke, no history of severe heart disease).

        Female x-linked CGD carriers must have greater than 30% normal neutrophils.

        EXC",4106092,"Carrier of disorder",TRUE
"NCT02614794","carrier","ment at least 12 months prior to starting study
                  treatment are eligible.

          -  Clinically significant cardiopulmonary disease

          -  Carriers of Hepatitis B or Hepatiti",4106092,"Carrier of disorder",TRUE
"NCT02976714","carrier","surance scheme

          -  women and men aged 12 to 30

          -  subject affected by cystic fibrosis, carrier of two severe mutations in trans (in the
             same allele) in the CFTR gene
",4106092,"Carrier of disorder",TRUE
"NCT03633019","carrier","plantation and other
             acquired/congenital immunodeficiency disorders

          -  patients with Hepatitis B(except inactive carrier) or Hepatitis C

          -  with serious heart diseas",4106092,"Carrier of disorder",TRUE
"NCT00584805","carrier","zation).

          -  Clinically significant abnormal lab results including evidence of Hepatitis C,
             Hepatitis B carrier state, or elevated (2X normal) liver function tests.

          -",4106092,"Carrier of disorder",TRUE
"NCT01627626","acute asthma","onths or more, and

          -  adults aged 20 years and older.

        Exclusion Criteria:

          -  acute asthma attack

          -  acute iritis

          -  narrow angle glaucoma

        ",4125022,"Acute asthma",FALSE
"NCT01045174","acute asthma","istory of asthma

          -  children must be presenting to the emergency department for treatment of acute asthma

          -  children must qualify to be treated for acute asthma according to an ",4125022,"Acute asthma",FALSE
"NCT00937924","acute asthma","y of allergic or adverse reactions to midazolam, diphenhydramine, or
             promethazine.

          -  Acute asthma, narrow angle glaucoma, concurrent use of potent inhibitors of CYP3A4
       ",4125022,"Acute asthma",FALSE
"NCT01662778","acute asthma","d specifically FP,
             listed in the British National Formulary will not be entered into this study

         11. Those who have experienced an acute asthma exacerbation requiring emergency r",4125022,"Acute asthma",FALSE
"NCT02111512","acute asthma","        for regular use by the child's treating healthcare professional

               -  Recent admission to hospital in last 2 weeks for acute asthma

               -  Current oral steroid for ast",4125022,"Acute asthma",FALSE
"NCT01019707","acute asthma","

         10. Have a significant family history of early cardiovascular morbidity or mortality.

         11. Have a diagnosis of adult asthma, including those with a history of acute asthma
        ",4125022,"Acute asthma",TRUE
"NCT03802227","acute asthma","determined by the MRI
             technologist and/or MRI physicist

          -  History of clinically significant acute asthma or other obstructive airway disease
             (e.g., chronic obstru",4125022,"Acute asthma",TRUE
"NCT01161303","acute asthma","        -  FEV1 of >60% predicted

        Exclusion criteria:

          -  Smokers

          -  Subjects with an acute asthmatic episode in the last 6 weeks

          -  Other significant clinical",4125022,"Acute asthma",TRUE
"NCT00252135","acute asthma"," Xolair therapy (e.g., patients who experienced a severe
             hypersensitivity reaction to Xolair)

          -  Acute asthma exacerbation within the previous 2 weeks of screening requiring an",4125022,"Acute asthma",TRUE
"NCT00801307","acute asthma","hma medication, no treatment for asthma in an emergency,acute care setting and
                  no admission to hospital for acute asthma

        Patients with moderate / severe COPD:

          -  ",4125022,"Acute asthma",TRUE
"NCT02169037","pericarditis"," during the procedure

        EXCLUSION CRITERIA:

          -  atrial fibrillation from a reversible cause (e.g., surgery, hyperthyroidism,
             pericarditis)

          -  cardiac or thorac",4138837,"Pericarditis",FALSE
"NCT03506412","pericarditis","r regurgitation (greater than moderate in severity),
             hypertrophic, restrictive or obstructive cardiomyopathy including amyloidosis,
             constrictive pericarditis, primary pulmona",4138837,"Pericarditis",FALSE
"NCT01148914","pericarditis","nd willing to give written consent

        Exclusion Criteria:

          -  Reversible causes of AF such as pericarditis and hyperthyroidism

          -  Associated chronic inflammatory diseases su",4138837,"Pericarditis",FALSE
"NCT04098328","pericarditis","       17. Infiltrative cardiomyopathies (e.g., amyloidosis, hemochromatosis, sarcoidosis),
             hypertrophic or restrictive cardiomyopathies, and constrictive pericarditis

         18. Activ",4138837,"Pericarditis",FALSE
"NCT02303379","pericarditis","able coronary heart disease

          -  state after heart surgeries

          -  state after myo-, endo-, or pericarditis

          -  state after heart- or lung-transplantation

          -  stat",4138837,"Pericarditis",FALSE
"NCT01889719","pericarditis","   -  Any clinically significant acute or chronic medical condition requiring care of a
             physician (e.g., diabetes, coronary artery disease, myopericarditis, grand-mal
             epileps",4138837,"Pericarditis",TRUE
"NCT00987415","pericarditis","vel > 250 pg/ml

        Exclusion Criteria:

          -  Hypertrophic or restrictive cardiomyopathy, constrictive pericarditis, biopsy-proven
             myocarditis, severe stenotic valvular disea",4138837,"Pericarditis",TRUE
"NCT01502462","pericarditis","ctive endocarditis requiring antibiotics therapy

          5. Untreated hyperthyroidism

          6. Constrictive pericarditis

          7. Unclosed significant atrial septal defect

          8. P",4138837,"Pericarditis",TRUE
"NCT03988166","pericarditis","c blood pressure <100 mmHg or cardiogenic shock

               -  Acute pulmonary edema or severe congestive heart failure

               -  Suspected acute myocarditis, pericarditis, endocarditis, ",4138837,"Pericarditis",TRUE
"NCT01246011","pericarditis","gery

         16. Aneurysm

         17. History of psychosis or senility

         18. Malignant hypertension

         19. Clinically significant pericarditis or pericardial effusion

         20. ",4138837,"Pericarditis",TRUE
"NCT04021797","major depression","lar functioning, including doctor diagnosed arrhythmia,
             bradycardia, hypertension, congestive heart failure, major depression, bipolar
             disorder, post-traumatic stress disorde",4152280,"Major depressive disorder",FALSE
"NCT01488058","major depressive disorder","stical Manual of the American Psychiatric Association - 4th
             edition (DSM-IV) criteria for Major Depressive Disorder,

          -  Internet access + printer access,

          -  Australi",4152280,"Major depressive disorder",FALSE
"NCT03522389","major depression","n Criteria:

          -  Having history of stroke or heart attack or Parkinsonism symptoms.

          -  The presence of major depression disorder deﬁned by a Patient Health Questionnaire-9 >
      ",4152280,"Major depressive disorder",FALSE
"NCT01834404","major depression","
          -  Use of anti-diabetic drugs other than metformin,

          -  History of nephrolithiasis,

          -  Recurrent major depression, presence or history of suicidal behavior or ideation ",4152280,"Major depressive disorder",FALSE
"NCT02327182","major depressive disorder","  Exclusion Criteria:

          -  Diagnosis of any other disease which may cause dementia

          -  Diagnosis of major depressive disorder as defined by Diagnostic and Statistical Manual
       ",4152280,"Major depressive disorder",FALSE
"NCT02285699","major depressive disorder","S score of ≥20.

          -  MADRS < 18

        Exclusion Criteria:

          -  Participants with current Major Depressive Disorder.

          -  Patients with significant suicidal ideation (MADR",4152280,"Major depressive disorder",TRUE
"NCT00435903","major depression","of schizophrenia, schizoaffective disorder,
             schizophreniform disorder, bipolar disorder, or major depression with significant
             functional impairment

          3. Smoking 10 o",4152280,"Major depressive disorder",TRUE
"NCT02347007","major depression","          -  Untreated or unstable hypothyroidism

          -  Hyperthyroidism

          -  Diagnosis of psychoses, bipolar disorder, major depression, severe personality
             disorder; hist",4152280,"Major depressive disorder",TRUE
"NCT00249535","major depression","serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar
             disorder, severe or psychotic major depression, or suicide risk)

          -  have dementia (<23 on the Mini",4152280,"Major depressive disorder",TRUE
"NCT00670098","major depression","severe cardiac and pulmonary diseases, as well as uncontrolled
             type 2 diabetes.

               -  Evidence of major depression or other psychiatric disorder (schizophrenia,
             ",4152280,"Major depressive disorder",TRUE
"NCT00906100","sinus bradycardia","IV heart failure despite a stable and optimized
             medical regimen

          -  Normal sinus rhythm or sinus bradycardia

        Exclusion Criteria:

          -  White-Parkinson-White syn",4171683,"Sinus bradycardia",FALSE
"NCT03971734","sinus bradycardia","ure

               -  Supraventricular tachycardia, atrial fibrillation, and/or atrial flutter

               -  Ventricular tachyarrhythmias

               -  Severe sinus bradycardia defined as a",4171683,"Sinus bradycardia",FALSE
"NCT00713323","sinus bradycardia","  infarction

          -  QT interval; of > 450 ms (males) or > 470 ms (females) at Visit 1

          -  Secondary or tertiary AV block or sinus bradycardia (HR <50bpm unless physiological)
        ",4171683,"Sinus bradycardia",FALSE
"NCT02869906","sinus bradycardia","sfunction (Ejection Fraction <30%).

          -  Heart Failure

          -  Previous STEMI

          -  Severe sinus bradycardia

          -  Past medical history of Asthma

          -  TIMI flow",4171683,"Sinus bradycardia",FALSE
"NCT01389583","sinus bradycardia","stasis

          5. Symptoms of heart failure or greater to Class III (by NYHA criteria) or history of
             uncontrolled dysrrhythmias

          6. Sinus bradycardia (resting heart rate <50 ",4171683,"Sinus bradycardia",FALSE
"NCT03436472","sinus bradycardia","urosurgery;

          -  Preoperative left ventricular ejection fraction < 30%, sick sinus syndrome, severe
             sinus bradycardia (< 50 beats per minute), or second-degree or greater
       ",4171683,"Sinus bradycardia",TRUE
"NCT03798821","sinus bradycardia","hial asthma, a history of bronchial asthma or severe chronic
             obstructive pulmonary disease.

          -  Sinus bradycardia, second or third degree of atrioventricular block, insufficienc",4171683,"Sinus bradycardia",TRUE
"NCT01284868","sinus bradycardia","severe
             hypersensitivity to any drug (excluding non-active hay fever)

          -  Any clinically significant history of sinus bradycardia, first and second degree
             atrioventr",4171683,"Sinus bradycardia",TRUE
"NCT01370070","sinus bradycardia","ock, 2nd or 3rd degree AV block, bifascicular block, sick sinus syndrome,
             Wolff-Parkinson-white syndrome, significant sinus bradycardia (< 50bpm) . However,
             patients with asy",4171683,"Sinus bradycardia",TRUE
"NCT03841383","sinus bradycardia","ocolate) sick sinus syndrome, advanced AV block (second and third degree),
                  systolic blood pressure < 90 mmHg, cerebral ischemia, severe sinus bradycardia
                  (heart rat",4171683,"Sinus bradycardia",TRUE
"NCT03439059","degenerative disorder","   -  any physical condition or disability disallowing participation in PA

          -  apparent evidence of any neurodegenerative disorders other than Alzheimer's disease

          -  score of 6 or",4179873,"Degenerative disorder",FALSE
"NCT02737930","degenerative disorder","r optic neuropathy

          -  Premorbid depression

          -  History of cognitive impairment, dementia, or neurodegenerative disorder

          -  History of seizure disorder

          -  His",4179873,"Degenerative disorder",FALSE
"NCT03757325","degenerative disorder","         -  Clinical history within 2 years of the screening visit or current evidence of any
             neurological or neurodegenerative disorder other than AD that is associated with
            ",4179873,"Degenerative disorder",FALSE
"NCT01737073","degenerative disorder","               -  osteoarthritis

               -  nerve compression

               -  other inflammatory and degenerative disorders

          -  receipt of chronic opioid therapy [90 continuous da",4179873,"Degenerative disorder",FALSE
"NCT00645190","degenerative disorder","sent form by subject and assent form by care-giver

        Exclusion Criteria:

          -  Patients with neurodegenerative disorders such as Parkinson's disease

          -  Patients with some con",4179873,"Degenerative disorder",FALSE
"NCT01163266","degenerative disorder","resence or history of a clinically significant neurological disorder (including
                  epilepsy)

               -  Neurodegenerative disorder.

               -  Any Axis II disorder that ",4179873,"Degenerative disorder",TRUE
"NCT01564862","degenerative disorder","reen prior to Baseline).

               4. Presence or history of a clinically significant neurological disorder (including
                  epilepsy).

               5. Neurodegenerative disorder ",4179873,"Degenerative disorder",TRUE
"NCT01255787","degenerative disorder","  -  Presence or history of a clinically significant neurological disorder (including
                  epilepsy).

               -  Neurodegenerative disorder. (Alzheimer's disease, Parkinson's dise",4179873,"Degenerative disorder",TRUE
"NCT01869868","degenerative disorder","  -  severe/life-threatening medical disease

          -  pregnancy

          -  type I diabetes

          -  neurodegenerative disorder

          -  inability to give written informed consent to ",4179873,"Degenerative disorder",TRUE
"NCT01965028","degenerative disorder","evidence of significant brain malformation or neoplasm, head injury

          -  Cerebral vascular events

          -  Neurodegenerative disorder affecting the brain or prior brain surgery

        ",4179873,"Degenerative disorder",TRUE
"NCT02505893","cytopenia","tance abuse

          -  Baseline Hb below the lower limits of normal at the local laboratory; lymphopenia
             (<1,000/µL), neutropenia (<1,500/µL), or thrombocytopenia (platelets <100,000/µ",4179922,"Cytopenia",FALSE
"NCT01422317","cytopenia","nancy, or other reasons

          -  Ongoing gastrointestinal bleeding or verified stomach ulcer

          -  Thrombocytopenia or blood platelets < 100 x 10'9/L

          -  Liver insufficiency

  ",4179922,"Cytopenia",FALSE
"NCT02056613","cytopenia","includes any of the following, as per AABB or FDA requirements
             for allogeneic use:

               -  Thrombocytopenia or other blood dyscrasias

               -  Bleeding diathesis

   ",4179922,"Cytopenia",FALSE
"NCT03181815","cytopenia","y of the subject to
             receive protocol therapy;

          -  Concurrent autoimmune hemolytic anemia or immune thrombocytopenia;

          -  Subjects suffered from AIDS，active hepatitis B",4179922,"Cytopenia",FALSE
"NCT01882829","cytopenia","           risk of complete AV block

          -  Participants with a history of quinidine, quinine or mefloquine-induced
             thrombocytopenia, hepatitis, or other hypersensitivity reactions",4179922,"Cytopenia",FALSE
"NCT02294994","cytopenia","rgery (including bypass surgery);

          -  Active bleeding

          -  Unexplained clinically significant bleeding, thrombocytopenia (platelet count < 100 x
             109/L) or history of th",4179922,"Cytopenia",TRUE
"NCT00671996","cytopenia",":

          1. Other tumour types than colon adenocarcinomas

          2. Current severe neutropenia, leucopenia or thrombocytopenia

          3. Severely reduced liver or renal function

         ",4179922,"Cytopenia",TRUE
"NCT02874586","cytopenia","            -  Patients with severe anemia (hemoglobin < 8 g/dL), leukopenia (WBC < 2500/mm3),
                  or thrombocytopenia (platelet count < 50,000/mm3);

               -  Severe disorders ",4179922,"Cytopenia",TRUE
"NCT01284322","cytopenia","ac disease with significant arrhythmia, heart failure, or
             unstable angina

          -  Anemia (Hb < 8.5 gm/dL)

          -  Thrombocytopenia or blood clotting disorder

          -  Pat",4179922,"Cytopenia",TRUE
"NCT02518594","cytopenia","equire invasive in-utero assessment or
             treatment, for example significant red cell antigen sensitization or neonatal
             alloimmune thrombocytopenia

         14. Major maternal ",4179922,"Cytopenia",TRUE
"NCT03816644","dementia","sessments.

          5. English or Spanish speaking.

        Exclusion Criteria:

          1. Prior diagnosis of dementia or MCI as ascertained by ICD-10 codes or the documentation
             of ",4182210,"Dementia",FALSE
"NCT01436045","dementia","          Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria and
             Dementia Rating Scale (McKhann 1984).

          -  Mini-Mental State Examination (MMSE) score ",4182210,"Dementia",FALSE
"NCT01601743","dementia","fetime history of schizophrenia, other psychotic
             illness, or bipolar illness; c. current organic brain disease or dementia assessed by
             clinical interview; d. current psychiat",4182210,"Dementia",FALSE
"NCT02895555","dementia","ed distance of walking due to non-spinal related causes.

          8. Candidate for more than two-level intervention.

          9. Dementia assessed by the MMSE

         10. ASA 3+4

         11. A",4182210,"Dementia",FALSE
"NCT03198741","dementia","rillator, or other ferromagnetic material; etc.

         23. Pregnant or plan to be pregnant within 1 year;

         24. Any condition that may interfere with any study procedures, such as dementia,",4182210,"Dementia",FALSE
"NCT03812523","dementia","-  Subjects with a history of or current tobacco or illegal substance use

          -  Subjects exhibiting significant psychiatric or cognitive impairment
             (dementia/delirium, retardation",4182210,"Dementia",TRUE
"NCT00130429","dementia","ria:

          -  Recent history or clinical evidence of significant neurological disease other than
             dementia due to Alzheimer's disease

          -  Known to have another condition tha",4182210,"Dementia",TRUE
"NCT03987061","dementia","er's disease,
             vasculitis)

          -  Severe medical comorbidities (untreated CAD/CHF, severe COPD, metastatic malignancy,
             dementia, etc) or other medical condition that wo",4182210,"Dementia",TRUE
"NCT03747042","dementia","ve mortality.

          5. Severe uncontrolled malabsorption condition or disease (i.e. grade II/III diarrhea,
             severe malnutrition, short gut syndrome)

          6. Dementia, altered me",4182210,"Dementia",TRUE
"NCT02163603","dementia","cated with mental, neurological disorders (such as hypoxic-ischemic
             encephalopathy, epilepsy and dementia) or significant barriers to growth.

          -  Patients are complicated with c",4182210,"Dementia",TRUE
"NCT02073214","birth asphyxia","3. Mother's age < 18 years

          4. Contraindicated to enteral nutrition within the first 48 hours of life

          5. Birth asphyxia (Apgar score: 0-3)

          6. Major congenital abnormali",4184996,"Birth asphyxia",FALSE
"NCT03171324","birth asphyxia","uct transfusion prior to study enrolment

          2. Neonatal jaundice due to hemolytic anemia

          3. Severe birth asphyxia defined as 1 minute Apgar score 0-3 with or without moderate to
   ",4184996,"Birth asphyxia",FALSE
"NCT00699413","birth asphyxia","viously diagnosed with any major illness since birth (e.g. sever intrauterine
             growth retardation, chronic birth asphyxia, cancer).

          -  Children with type 1 and/or type 2 diabete",4184996,"Birth asphyxia",FALSE
"NCT00555932","birth asphyxia","n MR and MRV as part of their diagnostic workup. Clinical
             indications for MR could include birth asphyxia, seizures, irritability, lethargy,
             abnormal neurological examination",4184996,"Birth asphyxia",FALSE
"NCT02970994","birth asphyxia","usion Criteria:

          -  Major congenital malformation

          -  Haemodynamic instability

          -  Birth asphyxia(Apgar score of less than 7 at 1 minute of age)

          -  Multiple ge",4184996,"Birth asphyxia",FALSE
"NCT00697580","birth asphyxia","viously diagnosed with any major illness since birth (e.g. severe intrauterine
             growth retardation, chronic birth asphyxia, cancer).

          -  Children will not be eligible for partici",4184996,"Birth asphyxia",TRUE
"NCT02056223","birth asphyxia"," than 50.000/mm3

          -  Proved Sepsis

          -  Severe coagulopathy or liver failure

          -  Evidence of severe birth asphyxia, that is an APGAR score below 5 at 5 minutes of age
    ",4184996,"Birth asphyxia",TRUE
"NCT02697110","birth asphyxia","ren aged 1-6 weeks

        Exclusion Criteria:

          -  Mothers of children with moderate to severe birth asphyxia or gross congenital
             anomalies

          -  Mothers who are unable",4184996,"Birth asphyxia",TRUE
"NCT02686060","birth asphyxia","""Outborn"" neonates,

          -  Newborns whose parental authority holders are minor,

          -  Newborns with severe birth asphyxia (cord blood pH<7.0 or Apgar score < 5 at 10 min),

          - ",4184996,"Birth asphyxia",TRUE
"NCT04073173","birth asphyxia","        -  late admission (after 24 hours of life),

          -  intubation in the delivery room,

          -  severe birth asphyxia,

          -  prolonged rupture of membranes,

          -  air ",4184996,"Birth asphyxia",TRUE
"NCT01225549","allergic asthma","teria:

          -  18-60 years of age

          -  Pre-bronchodilatory FEV1 ≥70% of predicted normal allergic asthmatic with a history of
             episodic wheeze

          -  Positive allerge",4191479,"Allergic asthma",FALSE
"NCT00829179","allergic asthma","illing to and competent to sign the consent form

        Exclusion Criteria:

          -  Subjects that do not have allergic asthma will be excluded.

          -  Subjects with ER visits or upper r",4191479,"Allergic asthma",FALSE
"NCT02014311","allergic asthma"," -  Known Iodine contrast allergy

          -  Estimated GFR below 50 ml/min

          -  Adenosine intolerance - known allergic asthma

          -  Previous CABG

          -  Patient related circ",4191479,"Allergic asthma",FALSE
"NCT03912402","atopic asthma","nfarction less than 6 months prior to
                  randomization;

               4. NYHA Grade III-IV congestive heart failure;

               5. atopic asthma, Stage III-IV COPD, angioedema;

",4191479,"Allergic asthma",FALSE
"NCT00160680","allergic asthma","  Subjects currently treated by specific parietaria pollen immunotherapy

          -  Subjects suffering from non-allergic asthma

          -  Chronic use of inhaled steroids and/or long acting β2 a",4191479,"Allergic asthma",FALSE
"NCT02387853","allergic asthma","ks prior to V1 or during the trial.

        Exclusion Criteria (for subjects performing HPA axis assessment):

          -  A history of serious allergy, allergic asthma or serious allergic skin rash",4191479,"Allergic asthma",TRUE
"NCT03517943","allergic asthma","own severe allergies (e.g., allergies to more than 3 allergens, allergies affecting
             the lower respiratory tract - allergic asthma, allergies requiring therapy with
             corticoste",4191479,"Allergic asthma",TRUE
"NCT01706484","allergic asthma","         -  Presence or history of uni- or bilateral nasal polyps

          -  Presence of moderate to severe co-morbid asthma, including allergic asthma

          -  Patients with mild asthma havin",4191479,"Allergic asthma",TRUE
"NCT01222351","allergic asthma","r or any of its constituents and/or has a history of severe
             allergic reactions to drugs or allergens (e.g. patients with allergic asthma)

          -  Critically ill and/or medically uns",4191479,"Allergic asthma",TRUE
"NCT01536041","allergic asthma","           endocrine, or pulmonary other than asthma

          -  Patients with Seasonal Allergic Rhinitis (SAR) or seasonal allergic asthma,with
             significant symptoms that may confound s",4191479,"Allergic asthma",TRUE
"NCT00000456","panic","y patient report, collateral report, and urine drug screen.

          -  Meets criteria for disorders of major depression, panic disorder, obsessive-compulsive
             disorder, post-traumatic s",4196358,"Panic",FALSE
"NCT04020653","panic","00 and 100,000 asexual
             parasite count/μL of blood.

             B. Fever, as defined by axillary/tympanic of ≥37.5°C within 24 hours before
             randomization (must be documented",4196358,"Panic",FALSE
"NCT01152957","panic","r those with diabetes diagnosed when
             under age 25).

          -  Patients who do not self identify as Hispanic

          -  Any life-threatening or extreme medical comorbidity

        ",4196358,"Panic",FALSE
"NCT03851133","panic","          biopsy, and/or blood-work and has not had treatment.

          -  Patient self-reports as Non-Hispanic White, African American, or Hispanic.

          -  Able to understand and voluntarily",4196358,"Panic",FALSE
"NCT01880411","panic","ordance with institutional guidelines

          -  Negative pregnancy test

          -  LSIL or HSIL on Papanicolaou (PAP) smear within the prior 6-8 weeks

          -  Normal electrocardiogram (EC",4196358,"Panic",FALSE
"NCT00911144","panic","ines.

          -  Major congenital defects or serious chronic illness.

          -  History of any neurologic disorders or seizures.

          -  Tympanic or axillary/ oral temperature >= 37.5°C o",4196358,"Panic",TRUE
"NCT01168687","panic","for lifetime abnormal opioid use or prescription drug abuse.

         11. Clinically significant medical or psychiatric illness (including anxiety or panic
             disorders) as determined by sc",4196358,"Panic",TRUE
"NCT02703389","panic","rs of children with severe symptoms (severe otalgia, fever > 39 C, impending
             perforation of tympanic membrane)

          -  caregivers who cannot readily access medical care

          -",4196358,"Panic",TRUE
"NCT01624428","panic","   -  Current diagnosis of any clinical significant psychiatric disease like major
             depressive disorder, panic or anxiety disorder, psychosis, schizophrenia, bipolar
             disorder.",4196358,"Panic",TRUE
"NCT04003389","panic","ave had a partial (supra-cervical) or full hysterectomy.

          -  Subject has documentation of a normal or not clinically significant Papanicolaou (Pap)
             test (or equivalent cervical ",4196358,"Panic",TRUE
"NCT02939378","hyperglycemia","ism, porphyria, carnitine deficiency and
             pancreatitis

          2. History of uncontrolled hyperlipidemia or hyperglycemia.

          3. History of human immunodeficiency virus, or hepa",4214376,"Hyperglycemia",FALSE
"NCT03849872","hyperglycaemia","thyroidism;

               4. Known diabetes mellitus type 1 or type 2;

               5. Hypocalcaemia or hypokalaemia;

               6. Hypoglycaemia or hyperglycaemia or fasting blood glucose o",4214376,"Hyperglycemia",FALSE
"NCT03609996","hyperglycemia","urrent regular use of insulin for the treatment of diabetes

               -  Current regular use of oral anti-hyperglycemia agents for the treatment of
                  diabetes

               -  ",4214376,"Hyperglycemia",FALSE
"NCT00488527","hyperglycemia","   agents) during more than 6 months, who need a prolonged action basal insulin to
             control hyperglycemia

          -  Glycosylated hemoglobin > 8,0% and < 10 %

          -  Body mass in",4214376,"Hyperglycemia",FALSE
"NCT02605616","hyperglycemia","-  Subjects with type 2 diabetes who are on stable doses of medications (except
             pioglitazone) to control hyperglycemia and have baseline HbA1c of 10% or lower.

          -  Hemoglobin mu",4214376,"Hyperglycemia",FALSE
"NCT00996892","hyperglycemia","eatment
             in Cycle 1

          -  History of diabetes requiring daily medication, or history of Grade >= 3 fasting
             hyperglycemia

          -  Current severe, uncontrolled sys",4214376,"Hyperglycemia",TRUE
"NCT02904512","hyperglycemia"," require a hospital stay ≤3 days

          -  Pregnant patients

          -  Subjects that have significant hyperglycemia or Diabetic Ketoacidosis (DKA) that
             requires treatment with int",4214376,"Hyperglycemia",TRUE
"NCT01099618","hyperglycemia","weight/obese (BMI >/=28 kg/m2) African-American patients with
             new-onset DKA and/or severe hyperglycemia and without apparent precipitating cause
             will be considered for inclus",4214376,"Hyperglycemia",TRUE
"NCT02581488","hyperglycemia"," metabolic instability (e.g., fever, chills,
             tachycardia, hypotension, confusion, vomiting, leukocytosis, acidosis, severe
             hyperglycemia, azotemia).

          6. A target ul",4214376,"Hyperglycemia",TRUE
"NCT00224822","hyperglycemia","         any clinically significant aspect of the metabolic syndrome including weight gain,
             hyperglycemia, diabetes, or hyperlipidemia, while on a second generation antipsychotic
        ",4214376,"Hyperglycemia",TRUE
"NCT01474538","lactic acidosis"," serum creatinine greater than or equal to 2 milligrams/deciliter (mg/dL) if not
             on metformin; known metabolic or lactic acidosis; any condition associated with
             hypoperfusion",4239233,"Lactic acidosis",FALSE
"NCT00108940","lactic acidosis","          Leukoencephalopathy), Fabry's disease, homocystinuria, MELAS (Mitochondrial myopathy,
             Encephalopathy, Lactic Acidosis, Stroke), or sickle cell anemia.

          -  The subject ",4239233,"Lactic acidosis",FALSE
"NCT02684474","lactic acidosis","tical ischemia, for example: elevated
             troponins, altered mental status, acute renal failure, lactic acidosis or evidence of
             central nervous system acute deficits

          3",4239233,"Lactic acidosis",FALSE
"NCT03038789","lactic acidosis","ollapse (shock), acute myocardial infarction, and
             septicemia.

          3. Patients with type 1 diabetes mellitus, lactic acidosis, or acute or chronic metabolic
             acidosis in",4239233,"Lactic acidosis",FALSE
"NCT01796028","lactic acidosis","th Metformin or an analog

          -  Known hypersensitivity or allergy to Metformin HCl or any of the excipients.

          -  Patients with a history of lactic acidosis

          -  PSA increase",4239233,"Lactic acidosis",FALSE
"NCT01825798","lactic acidosis","iver disease, renal impairment, congestive heart failure, pernicious
             anemia, any other condition increasing the risk for lactic acidosis, or any serious
             medical illness requi",4239233,"Lactic acidosis",TRUE
"NCT01546597","lactic acidosis","        -  Use of insulin therapy < 3 months prior to Screening

          -  History of ketoacidosis, ketosis-prone diabetes, or lactic acidosis

          -  Clinically significant complications of ",4239233,"Lactic acidosis",TRUE
"NCT02850848","lactic acidosis"," of drug or alcohol abuse during the past 24 weeks.

          2. Sensitivity to analogous drug.

          3. A clinically significant illness (such as lactic acidosis or severe hepatomegaly with
   ",4239233,"Lactic acidosis",TRUE
"NCT02279758","lactic acidosis"," Patient with hypersensitivity to biguanides, kidney or liver failure, or other
             conditions that predispose to lactic acidosis;

          -  History of severe clinical or psychiatric illn",4239233,"Lactic acidosis",TRUE
"NCT02822534","lactic acidosis","    -  ever occured acute complications of diabetes such as diabetic ketoacidosis,high
             permeability syndrome or lactic acidosis.

          -  ever occured the severe hypoglycemia.

     ",4239233,"Lactic acidosis",TRUE
"NCT02622724","muscular dystrophy","            Investigator, it would be extremely unlikely that the patient would come off
             ventilation, e.g., motor neurone disease, Duchenne muscular dystrophy or rapidly
             prog",4247802,"Muscular dystrophy",FALSE
"NCT02706574","muscular dystrophy","drome/Chronic Inflammatory Demyelinating Polyneuropathy, Significant
             Neurodegenerative Disorders, Muscular Dystrophy, and/or Malignant Intracranial Mass
             with Significant Mass",4247802,"Muscular dystrophy",FALSE
"NCT03986671","muscular dystrophy","ants with documented neurological disorders involving upper airway
        striated muscles including ALS and muscular dystrophy with the presence of bulbar symptoms.

        A cohort of participants",4247802,"Muscular dystrophy",FALSE
"NCT02121249","muscular dystrophy","     -  Primary abnormalities of bones (e.g. osteogenesis imperfecta)

          -  Primary muscle diseases, such as muscular dystrophy

          -  Neurologic diseases (e.g. Charcot-Marie Tooth, Gui",4247802,"Muscular dystrophy",FALSE
"NCT02184520","muscular dystrophy","ntent and
             there has been no clinical signs or symptoms of the malignancy for at least 5 years

          -  Neuromuscular disorders such as muscular dystrophy, spinal muscular atrophy,
  ",4247802,"Muscular dystrophy",FALSE
"NCT01008943","muscular dystrophy","  significant pelvic floor abnormalities with high pressure instability

          -  Neuromuscular disorder (e.g., muscular dystrophy, multiple sclerosis)

          -  Uncontrolled diabetes

       ",4247802,"Muscular dystrophy",TRUE
"NCT01300312","muscular dystrophy","       fracture, cancers, severe arthritis and osteoporosis.

          -  Muscular diseases such as myositis, poliomyelitis, muscular dystrophy and myotonia.

          -  Other known systemic diseas",4247802,"Muscular dystrophy",TRUE
"NCT04033588","muscular dystrophy"," Subjects with other significant disabling problems from the muscular-skeletal system
             other than in the knees (i.e muscular dystrophy, polio, neuropathic joints).

          -  Subjects w",4247802,"Muscular dystrophy",TRUE
"NCT02954354","muscular dystrophy","scle (eg, cerebral palsy, epilepsy [seizure
                  disorders], stroke, intellectual disability, moderate to severe developmental
                  delay, muscular dystrophy, or spinal cord ",4247802,"Muscular dystrophy",TRUE
"NCT03153475","muscular dystrophy"," significant neurological or musculoskeletal disorder(s) or disease that
             may adversely affect gait or weight bearing activities (e.g., muscular dystrophy,
             multiple sclerosis,",4247802,"Muscular dystrophy",TRUE
"NCT03159208","respiratory failure","  acute illness.

          3. Adults >/= 18yo of age.

        Exclusion Criteria

          1. Patients with respiratory failure due to neuromuscular disease

          2. Patients with respiratory ",4256228,"Respiratory failure",FALSE
"NCT02752100","respiratory failure","       encephalopathy.

          -  History of dialysis.

          -  Chronic obstructive pulmonary disease (COPD), chronic respiratory failure or
             hypoxemia.

          -  Acute infecti",4256228,"Respiratory failure",FALSE
"NCT01862016","respiratory failure","         nodules lung

          -  Report PaO2 / FiO2 ≤ 200 mmHg with a PEP of at least 5 cmH2O

          -  Respiratory failure not fully explained by cardiac failure or fluid overload

          -",4256228,"Respiratory failure",FALSE
"NCT02945956","respiratory failure","ocytosis) or Hemolytic anemia patients caused by other reasons
             like autoimmunity.

          -  Severe background disease like chronic respiratory failure, circulatory failure,
          ",4256228,"Respiratory failure",FALSE
"NCT01095575","respiratory failure","ulants during 21 days prior to surgery, psychiatric
             illness

          3. congestive heart failure, respiratory failure, neuromuscular disease or presence of a
             chronic pain s",4256228,"Respiratory failure",FALSE
"NCT02938741","respiratory failure","priate for HSCT. Life expectancy < 3 months because of
        other severe diseases. Presence of any fatal disease, including respiratory failure, heart
        failure, liver or kidney function fail",4256228,"Respiratory failure",TRUE
"NCT02723942","respiratory failure","    3. renal function:Chronic kidney disease(CKD) phase 4 or more; renal insufficiency
                  phase Ⅲ or more.

               4. pulmonary function：severe respiratory failure symptoms, inv",4256228,"Respiratory failure",TRUE
"NCT00546975","respiratory failure","      5. Patients taking supplements (EPA, DHA)

          6. Any concomitant severe disease e.g.

               -  Patients with respiratory failure (FEV<0.8l/sec)

               -  Patients with r",4256228,"Respiratory failure",TRUE
"NCT03095300","respiratory failure"," reliable estimate of the actual one.

          3. PaCO2 <45mmHg

          4. Absence of history of chronic respiratory failure or moderate to severe cardiac
             insufficiency (NYHA > II or",4256228,"Respiratory failure",TRUE
"NCT02590159","respiratory failure","  -  Uncontrolled or serious illness, including but not limited to: severe breathing
             disorders including hypercapnic respiratory failure, respiratory muscle weakness,
             bullous",4256228,"Respiratory failure",TRUE
"NCT00063336","visual impairment","a minimum of 6 months prior to
             study entry

        Exclusion Criteria:

          -  Auditory or visual impairment

          -  Mental retardation (IQ less than 70)

          -  Trauma",4265433,"Visual impairment",FALSE
"NCT02233478","visual impairment","g systemic chemotherapy and/or radiotherapy.

          -  Active bleeding.

          -  Subject has any disorder (excluding illiteracy or visual impairment) that compromises
             the ability",4265433,"Visual impairment",FALSE
"NCT02188628","visual impairment","gers incompatible with interface with the H-man robot.

          -  Severe sensory impairment of affected limb

          -  Severe visual impairment, hemispatial neglect or homonymous hemianopia

  ",4265433,"Visual impairment",FALSE
"NCT03118986","visual impairment","id)

          -  Previous participation in this study.

          -  Participants in the optional assessment of nausea severity must be free of cognitive,
             hearing or visual impairment th",4265433,"Visual impairment",FALSE
"NCT00617318","visual impairment","medical condition that may interfere with study protocol
             adherence.

          -  Subject has any disorder (excluding illiteracy or visual impairment) that compromises
             the ab",4265433,"Visual impairment",FALSE
"NCT03518346","visual impairment","on criteria.

        Exclusion Criteria:

          1. History of seizures.

          2. Vision loss or significant visual impairment to the degree that the participant is
             unable to see",4265433,"Visual impairment",TRUE
"NCT01432418","visual impairment"," have a rapidly progressive disorder (e.g. amyotrophic lateral sclerosis or terminal
             cancer)

          -  have significant visual impairments (legally blind)

          -  have unstable ",4265433,"Visual impairment",TRUE
"NCT03684850","impaired vision","  -  superficial wounds at the knee area

          -  arterial insufficiency

          -  severe varicosities

          -  impaired vision

          -  postural difficulties

          -  body-mas",4265433,"Visual impairment",TRUE
"NCT03330236","visual impairment","lity to communicate in the preoperative period due to illiteracy, language
             difficulties, or significant hearing or visual impairment;

          7. Inability to complete MMSE and delirium",4265433,"Visual impairment",TRUE
"NCT03550339","visual impairment","    -  right-handed

        Exclusion Criteria:

          -  pregnancy or breast feeding

          -  severe visual impairments, severe scalp skin lesions or intracranial bleeding during
          ",4265433,"Visual impairment",TRUE
"NCT02543060","gingivitis","dence of:

          -  Have had a dental prophylaxis within 2 weeks of plaque sampling visits;

          -  Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products
       ",4281516,"Gingivitis",FALSE
"NCT03989427","gingivitis","cal College

        Exclusion Criteria:

          -  Participants who had systemic diseases

          -  Gingivitis or periodontitis

          -  Use of antibiotics in the past 3 months,

        ",4281516,"Gingivitis",FALSE
"NCT02709785","gingivitis","riteria:

          -  Subjects between the ages of 18 to 80

          -  Subjects with a diagnosis of gingivitis or chronic periodontitis

          -  Entry levels of gingival inflammation and plaq",4281516,"Gingivitis",FALSE
"NCT02816593","gingivitis","ons without
             whitening experience

        Exclusion Criteria:

          -  participants with gingivitis and periodontal disease, the total biofilm accumulation
             greater than ",4281516,"Gingivitis",FALSE
"NCT01559987","gingivitis","lection,
             for definition);

          -  present with one of the following three categories:

          -  BGI-gingivitis: all PD<3mm, BOP>10%;

          -  BGI-periodontitis (P2): 1+ sit",4281516,"Gingivitis",FALSE
"NCT03873038","gingivitis","     the last 5 years or severe hemorrhoidal bleed in last 3 months.

          -  Has a history of or current frequent epistaxis within the last 3 months or active
             gingivitis.

         ",4281516,"Gingivitis",TRUE
"NCT03087786","gingivitis","r recurrent disease that could affect the site of application, the
                  action, absorption of the study treatment, or clinical assessment.

               4. Has severe gingivitis, period",4281516,"Gingivitis",TRUE
"NCT01548469","gingivitis","severe suppuration caused by pericoronitis of the wisdom tooth.

          4. Who has hypersensitive conditions caused by Gingivitis or periodontitis.

          5. Who having restorative dentistry or",4281516,"Gingivitis",TRUE
"NCT01700348","gingivitis","          (including aspirin);

          -  have heavy deposits of calculus, either supragingival and/or subgingival;

          -  have severe gingivitis or periodontitis;

          -  have extensi",4281516,"Gingivitis",TRUE
"NCT01009554","gingivitis","           toothpastes and mouthrinses.

          -  History or current evidence of significant oral soft tissue pathology, excluding
             gingivitis, based on the dentist's visual examinatio",4281516,"Gingivitis",TRUE
"NCT03847272","macular edema"," Miami 9-step scale (or VH >1+ according to SUN
                  classification)

               -  and/or macular edema on OCT (Central retinal thickness ≥ 300 microns)

               -  and/or oth",4290333,"Macular retinal edema",FALSE
"NCT02055911","macular edema","        -  Patients with Type 1 or Type 2 diabetes mellitus and prior diagnosis of diabetic
             macular edema (DME), who had not undergone any previous treatment, either
             pharmaco",4290333,"Macular retinal edema",FALSE
"NCT04060758","macular oedema"," narrow angles. Note: Previous laser peripheral iridotomy is NOT acceptable.

          -  Have a history of or current uveitis, cystoid macular oedema (CME), or cornea oedema
             in the stud",4290333,"Macular retinal edema",FALSE
"NCT00695682","macular edema"," which did not improve with
             conventional therapy

          -  Patients with refractory diabetic macular edema in the study eye which did not improve
             with conventional therap",4290333,"Macular retinal edema",FALSE
"NCT01213888","macular edema","thickness is acceptable)

          -  No other ocular disease that could be responsible for decreased vision, macular edema
             or could limit macular imaging

        Exclusion Criteria:

 ",4290333,"Macular retinal edema",FALSE
"NCT04018833","macular edema"," such as:

          -  significant vitreoretinal interface abnormality on SD-OCT that may contribute to
             macular edema

          -  age-related macular degeneration

          -  retinal",4290333,"Macular retinal edema",TRUE
"NCT03943498","macular edema","schemic heart disease, cardiac
             arrest, cerebrovascular disease, uncontrolled hypertension, symptomatic bradycardia,
             macular edema, recurrent syncope, severe untreated sleep a",4290333,"Macular retinal edema",TRUE
"NCT03475407","macular edema","     -  Patients of Non Proliferative Diabetic Retinopathy(NPDR) with clinically significant
             macular edema(CSME)

          -  Patients with Proliferative Diabetic Retinopathy(PDR) with C",4290333,"Macular retinal edema",TRUE
"NCT01169779","macular edema","pretation of the study results difficult,
             history or presence of clinically significant diabetic retinopathy, history or
             presence of macular edema likely to require laser tre",4290333,"Macular retinal edema",TRUE
"NCT01646047","macular edema","proliferative diabetic retinopathy or severe non-proliferative retinopathy

          -  clinically significant macular edema

          -  corrected visual acuity less than 20/30 in either eye

     ",4290333,"Macular retinal edema",TRUE
"NCT02653963","postoperative complication","    concomitant procedures such as deep vitrectomy or cataract surgery, and any major
             intra- or postoperative complication which could affect the outcomes of surgery.

          -  Patien",4300243,"Postoperative complication",FALSE
"NCT03763084","postoperative complication","ophen or morphine or to any of the excipients in the IV or oral
                  formulations used.

               8. Subject has intra- or postoperative complications, which in the view of the
    ",4300243,"Postoperative complication",FALSE
"NCT00003409","postoperative complication"," prior radiotherapy to face, head, or neck Surgery: See
        Disease Characteristics Recovered from prior surgery or postoperative complication Other:
        At least 48 hours since prior MRI scan",4300243,"Postoperative complication",FALSE
"NCT02148848","postoperative complication","   -  Patients who were treated with bipolar hemiarthroplasty for more than 2 weeks

          -  Patients with postoperative complications which affect the postoperative
             rehabilitation p",4300243,"Postoperative complication",FALSE
"NCT01424150","postoperative complication","radical
             hysterectomy, and abdominal incisional hernia repair)

          3. At increased risk of postoperative complications, defined as at least one of the
             following criteri",4300243,"Postoperative complication",FALSE
"NCT03547804","postoperative complication","ntification> 1.0 g;

             9, combined with anastomotic leakage, duodenal stump fistula, pancreatic fistula or
             anastomotic stenosis and other serious postoperative complications;

",4300243,"Postoperative complication",TRUE
"NCT02974426","postoperative complication","r basal cell
             carcinoma of the skin or carcinoma in situ of the cervix within the last 5 years;

          -  Patients with severe postoperative complications; and time to beginning of the",4300243,"Postoperative complication",TRUE
"NCT01914406","postoperative complication","written informed consent for study participation.

        Exclusion Criteria:

        unstable condition postoperative complications, recent severe rejection episodes (>H1R < 3
        month), re-tr",4300243,"Postoperative complication",TRUE
"NCT00905645","postoperative complication"," Pregnant or lactating

          -  Medical condition that might result in unduly high surgical risk and/or significant
             postoperative complications, in the judgment of the Investigator

",4300243,"Postoperative complication",TRUE
"NCT02891083","postoperative complication","ugh Left thoracic or transhiatal approach, whereby complete
             lymphadenectomy is not achieved;

          2. Patients experienced severe postoperative complication and thus, are unable to
 ",4300243,"Postoperative complication",TRUE
"NCT02617368","corneal scar","xclusion Criteria:

          -  for all study groups:

               -  previous incisional eye surgery

               -  corneal scars and opacities

               -  history of herpetic keratiti",4318992,"Corneal scar",FALSE
"NCT01787760","corneal scar","orneal irregularity in either eye

         13. Strabismus in either eye

         14. Pupil or lid abnormality or infection in either eye

         15. Central corneal scar and aphakia in either eye
",4318992,"Corneal scar",FALSE
"NCT03660345","corneal scar","n of macular edema (e.g., foveal atrophy,
             pigment abnormalities, dense subfoveal hard exudates, a nonretinal condition like
             corneal scarring or advanced optic nerve cupping f",4318992,"Corneal scar",FALSE
"NCT03626376","corneal scar"," immune stromal keratitis with or without epithelial
             ulceration, endothelitis, or iridocyclitis and corneal scarring in the central 4mm
             zone.

        Exclusion Criteria:

  ",4318992,"Corneal scar",FALSE
"NCT02412215","corneal scar","    -  Zonular fibres pathologies (phacodonesis, pseudoexfoliation syndrome)

          -  Irregular astigmatism (corneal scar, keratoconus, pterygium)

          -  Traumatic cataract

          -  P",4318992,"Corneal scar",FALSE
"NCT00706940","corneal scar","ögren's syndrome

          4. Has any clinically significant lid or conjunctival abnormalities, neovascularization,
             corneal scars or corneal opacities;

          5. Has limbal or bulbar",4318992,"Corneal scar",TRUE
"NCT01152541","corneal scar","e(s) to be treated
             that may predispose the eye for future complications

          -  Clinically significant corneal scarring in the CXL treatment zone

          -  Pregnancy (including ",4318992,"Corneal scar",TRUE
"NCT03209505","corneal scar","         Syndrome, etc.) or significant Dry Eye Syndrome

          8. Has clinically significant corneal vascularization or central corneal scaring

          9. Has active ocular surface infection (",4318992,"Corneal scar",TRUE
"NCT01809834","corneal scar","      fluorescein dye;

          -  Has any clinically significant lid or conjunctival abnormalities, neovascularization,
             corneal scars or corneal opacities;

          -  Is aphakic;

 ",4318992,"Corneal scar",TRUE
"NCT03951610","corneal scar","uorescein dye.

          -  Has any clinically significant lid or conjunctival abnormalities, active
             neovascularization or any central corneal scars.

          -  Is aphakic.

         ",4318992,"Corneal scar",TRUE
"NCT00399568","pain","l (spinal or epidural) opioid analgesics prior to or during
             surgery

          -  Moderate to Severe pain at rest

        Exclusion Criteria:

          -  Requires any additional surgic",4329041,"Pain",FALSE
"NCT04044729","pain","nclusion Criteria:

          -  Age between 18-50 yrs.

          -  Chronic musculoskeletal and joint pain for at least 3 months or longer.

          -  Participants must live within a 60 mile radi",4329041,"Pain",FALSE
"NCT03822273","pain","e, unilateral or bilateral rib fractures diagnosed with chest
             X‑ray

          -  Maximal rib pain score of more than 5 obtained using the numerical rating scale (NRS:
             0‑10)
",4329041,"Pain",FALSE
"NCT00541164","pain","heir primary care physician (PCP) to enroll in
             the study

          -  Regarding weakness, fatigue, and pain, subjects must experience at least two of the
             three symptoms on m",4329041,"Pain",FALSE
"NCT00114374","pain","idepressants, with the exception of trazodone < 100mg/day
             for sleep, or amitriptyline in doses ≤ 50 mg daily for pain. Patients may remain on
             concomitant benzodiazepines (<2 ",4329041,"Pain",FALSE
"NCT03342391","pain","oduced).

          8. EoE has been symptomatic with clinically significant symptoms attributable to EoE
             including dysphagia, abdominal pain or vomiting in the period since endoscopy

   ",4329041,"Pain",TRUE
"NCT00376675","pain"," BP ≥ 100 mmHg on 2 separate visits ≤ 2 months prior to randomization]; or a
             resting heart rate > 100

          5. Moderate or severe pain as defined by an average daily score ≥ 4 on a p",4329041,"Pain",TRUE
"NCT03551587","pain"," or slight widening in lamina dura.

        Exclusion Criteria:

          -  Patients on medication for chronic pain.

          -  Patients having significant systemic disorders.

          -  Teet",4329041,"Pain",TRUE
"NCT03959059","pain"," Single level OVCF in the thoracic and lumbar levels (T10-L4), suffering with severe
             back pain.;

          -  OVCF without damaged vertebral posterior wall and nerve lesion;

          -",4329041,"Pain",TRUE
"NCT02123979","pain"," categorized as partial-boney or full-boney impactions

               -  Self-report of moderate or severe pain on a categorical scale with a minimum of 5
                  out of 10 on the numerical",4329041,"Pain",TRUE
"NCT03960697","mental retardation","diastolic blood
             pressure > 90 mmHg );

          5. Patients have schizophrenia, epilepsy, Parkinson's disease, mental retardation, or
             hearing impairment.

          6. Patie",40277917,"Intellectual disability",FALSE
"NCT03352375","mental retardation","astroesophageal regurgitation risk, reactive airway hiatal
             hernia, peripheric vascular disease, mental retardation, neuropsychiatric illness or
             an lung infection during the l",40277917,"Intellectual disability",FALSE
"NCT01962129","mental retardation","mptomatic relatives have
        to be covered by a national health insurance agency.

        Group 2: Study of the form of syndromic X-linked mental retardation secondary to mutations
        in the",40277917,"Intellectual disability",FALSE
"NCT00070954","mental retardation","a

          -  Psychotic symptoms

          -  Lifetime history of schizophrenia, schizoaffective disorder, or mental retardation

          -  Diagnosis of anxiety disorder, obsessive-compulsive di",40277917,"Intellectual disability",FALSE
"NCT01911442","intellectual disability"," be stable for at least 4
             weeks before screening and consistent throughout the study.

        Exclusion Criteria:

          -  Subjects with profound intellectual disability.

         ",40277917,"Intellectual disability",FALSE
"NCT01157494","mental retardation"," or functional surgery on the plegic UE 6 months prior
             to the video recordings

          -  severe mental retardation attested by the Diagnostic and Statistical Manual of mental
        ",40277917,"Intellectual disability",TRUE
"NCT03452605","mental retardation","
          -  history or MRI evidence of brain damage, including significant trauma, stroke,
             hydrocephalus, mental retardation, or serious neurological disorder,

          -  significant",40277917,"Intellectual disability",TRUE
"NCT03723876","intellectual disability","          -  accepted for care at habilitation unit

        Exclusion Criteria:

          -  diagnosed with intellectual disability (F70*-F73*, F78*-F79* in ICD-10)

          -  medium or severe de",40277917,"Intellectual disability",TRUE
"NCT02963870","intellectual disability","pt

          -  mental disorders significantly impair the self-assessment questionnaire capacities:
             Intellectual disability, autism spectrum disorder, acute psychotic state and,
        ",40277917,"Intellectual disability",TRUE
"NCT00154154","mental retardation","

          -  Psychotic disorder,bipolar I disorder, or dementia

          -  Evidence of an organic brain syndrome or mental retardation

          -  A chronic or serious physical health problem t",40277917,"Intellectual disability",TRUE
"NCT01596699","combined immunodeficiency disease","Anemia

          -  Dyskeratosis Congenita

          -  A known syndrome with increased sensitivity to radiation or alkylating agents

          -  Severe Combined Immunodeficiency Disease eligible ",40483560,"Combined immunodeficiency disease",FALSE
"NCT01960725","combined immunodeficiency disease","        1. History of hypersensitivity to the vaccine or any component of the vaccine

          2. History of Severe Combined Immunodeficiency Disease (SCID)

          3. History of immunocompromise",40483560,"Combined immunodeficiency disease",FALSE
"NCT03166397","combined immunodeficiency disease","arction, cardiac
             arrhythmias, obstructive or restrictive pulmonary disease.

          4. Any form of primary immunodeficiency (such as Severe Combined Immunodeficiency Disease
          ",40483560,"Combined immunodeficiency disease",FALSE
"NCT01000974","combined immunodeficiency disease","of uncorrected congenital malformation of the gastrointestinal tract that
             would predispose the infant to intussusception.

          -  History of Severe Combined Immunodeficiency Disease",40483560,"Combined immunodeficiency disease",FALSE
"NCT00301834","combined immunodeficiency disease","immunodeficiency disease

                    -  Chediak-Higashi disease

                    -  Wiskott-Aldrich syndrome

                    -  Combined immunodeficiency disease (Nezelof's)

       ",40483560,"Combined immunodeficiency disease",FALSE
"NCT03587389","combined immunodeficiency disease","ntestinal tract in
             the child that is likely to predispose child to intussusception.

          -  History of severe combined immunodeficiency disease (SCID), acquired immune deficiency
  ",40483560,"Combined immunodeficiency disease",TRUE
"NCT02422264","combined immunodeficiency disease","virus and hepatitis
             B diseases.

          -  Any confirmed or suspected immunosuppressive or immunodeficient condition including
             severe combined immunodeficiency disease (SC",40483560,"Combined immunodeficiency disease",TRUE
"NCT03834233","combined immunodeficiency disease","hildhood asthma/atopy.

          -  Evidence of clinically significant immunosuppression, including primary
             immunodeficiency state such as Severe Combined Immunodeficiency Disease or con",40483560,"Combined immunodeficiency disease",TRUE
"NCT00972400","combined immunodeficiency disease","ent English language skills

          -  No significant cognitive impairment

          -  No concurrent severe combined immunodeficiency disease

        PRIOR CONCURRENT THERAPY:

          -  See ",40483560,"Combined immunodeficiency disease",TRUE
"NCT00863330","combined immunodeficiency disease","          completion of study treatment

          -  No HIV or hepatitis B or C positivity

          -  No form of primary immunodeficiency (e.g., severe combined immunodeficiency disease or
       ",40483560,"Combined immunodeficiency disease",TRUE
"NCT02403960","oral lesion","  phenytoin, cyclosporin, chronic use of non-steroidal anti-inflammatory drugs),

          3. pregnancy,

          4. acute oral lesions or necrotizing ulcerative periodontitis and

          5. den",43530620,"Oral lesion",FALSE
"NCT01514552","oral lesion","l treatment during the study period.

          -  Have noticeable open lesions, sores that have not healed for more than 3 months, have
             had any active oral lesions or maladies within the",43530620,"Oral lesion",FALSE
"NCT00837174","oral lesion","or tumor mass that can be accurately measured in two dimensions by
                  CT,MRI, medical photograph (skin or oral lesion), plain X-ray, PET scan or other
                  conventional tec",43530620,"Oral lesion",FALSE
"NCT03572959","oral lesion","iteria (Meji and van der Waal
             2003).

          -  presence of painful and atrophic-erosive oral lesions, unresponsive to topical
             corticosteroid therapy

          -  ability",43530620,"Oral lesion",FALSE
"NCT03141554","oral lesion","ng consent and during the study,

          -  Good oral health (e.g., no visible bleeding, inflammation, oral ulcer or oral lesion,
             no need for dental treatment),

          -  Must have",43530620,"Oral lesion",FALSE
"NCT02894593","oral lesion","eeth per quadrant)

          -  age between 20 and 50 years old

        Exclusion Criteria:

          -  oral lesions

          -  severe periodontal problems (probing depth ≥5 mm or attachment lo",43530620,"Oral lesion",TRUE
"NCT01674504","oral lesion","sing.

          -  Clinically significant abnormalities and / or with significant diseases.

          -  Prevalence of oral candidiasis, aphthous ulcer or other oral lesions.

          -  Difficult",43530620,"Oral lesion",TRUE
"NCT01962493","oral lesion","ucts; severe
             periodontitis; severe recession; dental implants; active carious lesions on anterior
             teeth; oral lesions/manifestations; prone to aphthous stomatitis and ulcerat",43530620,"Oral lesion",TRUE
"NCT03351530","oral lesion","dontal pocket≧7 mm, and
        radiographic bone loss≧30%

        Exclusion Criteria:

          1. People who have oral lesion, dental braces, denture, mouthwash allergy, or serious
             sy",43530620,"Oral lesion",TRUE
"NCT01816841","oral lesion","The Ohio State University James
             Cancer Hospital Otolaryngology Department with a suspicious oral lesion or prior
             biopsy-confirmed epithelial dysplasia (mild, moderate, severe",43530620,"Oral lesion",TRUE
"NCT03328182","dermatitis","nificant skin disease or condition, or damaged skin on the
             application site, such as psoriasis, eczema, atopic dermatitis, active cancer, sores,
             sunburns, scars, moles

     ",45766714,"Inflammatory dermatosis",FALSE
"NCT01536886","dermatitis","phic skin, striae atrophicae, fragility of skin veins, icthyosis,
             ulcers and wounds.

          -  Other inflammatory skin disorders (e.g. seborrhoeic dermatitis or contact dermatitis)
  ",45766714,"Inflammatory dermatosis",FALSE
"NCT01666509","dermatitis","  Flushing due to conditions other than rosacea

          -  Any other abnormal facial skin conditions, e.g., eczema, perioral dermatitis, broken
             and bleeding skin on area of application",45766714,"Inflammatory dermatosis",FALSE
"NCT00549601","dermatitis","revent accurate
             assessment of the adhesion and potential skin irritation of the patch (e.g., atopic
             dermatitis, wounded or scratched skin in the area of the patch application",45766714,"Inflammatory dermatosis",FALSE
"NCT00521040","dermatitis","se of inhaled steroids and/or long acting β2 agonists; and/or corticosteroid
             dependent asthma

          -  atopic dermatitis or urticaria requiring an antihistamine treatment or the
    ",45766714,"Inflammatory dermatosis",FALSE
"NCT02938494","dermatitis"," interfere with clinical
             evaluations such as acne conglobata, acne fulminans, secondary acne, perioral
             dermatitis, clinically significant rosacea, gramnegative folliculitis, ",45766714,"Inflammatory dermatosis",TRUE
"NCT03186378","dermatitis","y significant medical history as
             determined by the investigator. Patients exhibiting active Atopic Dermatitis may be
             enrolled.

          5. Refrain from application of all t",45766714,"Inflammatory dermatosis",TRUE
"NCT03855696","dermatitis","c disease

               5. Clinically significant allergic disease (however, mild allergic rhinitis or
                  allergic dermatitis not requiring any medication is allowed) or history of an",45766714,"Inflammatory dermatosis",TRUE
"NCT02797678","dermatitis"," could increase the chance of seizures (e.g. stroke,
             aneurysm, brain surgery, structural brain lesion).

          -  Individuals who self-report severe contact dermatitis.

          -  ",45766714,"Inflammatory dermatosis",TRUE
"NCT01095055","dermatitis","erbated by any component of
             the vaccine, e.g. egg products, Kathon.

          -  History of clinically significant contact dermatitis

          -  Any history of anaphylaxis in reaction",45766714,"Inflammatory dermatosis",TRUE
"NCT03257995","asthma attack","alactose intolerance, Lapp lactase
        deficiency or glucose-galactose malabsorption)

          -  Patients who have had an asthma attack/exacerbation requiring systemic steroids or
             ",45771045,"Acute exacerbation of asthma",FALSE
"NCT03630432","asthma attack","          Network(SIGN)/British Thoracic Society(BTS) guideline 2014 as persistent symptoms
             and/or frequent asthma attacks despite treatment at step 4 or step 5 with either:

            ",45771045,"Acute exacerbation of asthma",FALSE
"NCT03779152","asthma attack","ackground treatment

          2. patients with intermittent asthma =

               -  being asymptomatic between asthma attacks,

               -  with symptoms less than once a week

            ",45771045,"Acute exacerbation of asthma",FALSE
"NCT02557633","asthma attack","rmittent asthma

               -  Emergency room visit or admission for asthma in the 12 months prior to Visit 1 or
                  history of a life-threatening asthma attack ever

               ",45771045,"Acute exacerbation of asthma",FALSE
"NCT00624832","asthma attack","       -  Current active smokers

          -  Patients who have been hospitalized or had emergency treatment for an asthma attack in
             the 12 months prior to study start

          -  Hist",45771045,"Acute exacerbation of asthma",FALSE
"NCT00569192","asthma attack","ower respiratory tract infection, within 2 weeks of
             screening.

          -  Any history of acute or severe asthma attack requiring ICU admission or ventilatory
             support.

   ",45771045,"Acute exacerbation of asthma",TRUE
"NCT01165281","asthma attack","contraindicated such as serious respiratory
             depression of serious chronic obstructive pulmonary disease, bronchial asthma attack,
             cardiac failure secondary to chronic pulmona",45771045,"Acute exacerbation of asthma",TRUE
"NCT03549923","asthma attack","          1. Age < 18 years

          2. Contraindications or intolerance to beta-blockers

               -  Moderate or severe bronchial asthma attack or history of bronchial asthma

              ",45771045,"Acute exacerbation of asthma",TRUE
"NCT00643578","asthma attack"," >10 pack-year smoking history

          -  Respiratory tract infection within the last four weeks

          -  History of severe asthma attack requiring hospitalization in the previous 12 months

 ",45771045,"Acute exacerbation of asthma",TRUE
"NCT02478398","asthma attack","as severe, unstable, or uncontrolled asthma, as judged by the clinical investigator,
             or has experienced a life-threatening asthma attack or an occurrence of any clinical
             dete",45771045,"Acute exacerbation of asthma",TRUE
